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Abstract 
 
Establishment of accurate cancer diagnosis involves a series of complex medical 
procedures and is rarely straightforward. These diagnoses are reliant upon the results 
of multiple medical examinations comprising of non-invasive imaging for disease 
localisation, histopathology analysis of tissue specimens and genetic sequencing to 
differentiate mutation subtypes. Although medical imaging and general pathology are 
becoming more routine, genetic sequencing is not always practical as human cancers 
exhibit strong phenotypic and genetic heterogeneity, which requires multiple site 
sampling in addition to its high cost and accessibility. 
 Medical imaging provides non-invasive assessments of phenotypic diversities 
in a number of cancer types. Medical images have the potential to offer insights into 
the patterns of disease spread and treatment response. Furthermore, advances in 
computerised medical image analysis enable the extraction of tumours’ visual 
representation (features) to facilitate characterising tumour phenotypes. The 
association between tumour imaging biomarkers and existing genetic foreknowledge 
lead to the emergence of image-genomics. 
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Image-genomics leverages medical image analysis and genetic information to 
provide a complementary approach that contributes to a non-invasive and accurate 
cancer diagnosis. This is achieved through associating tumour imaging traits with 
clinical data (e.g., the underlying tumour genetic information), where recent image-
genomics research has demonstrated its potential to identify imaging surrogates for 
tumour biomarkers. 
However, the majority of image-genomics research has focused on the 
employment of tumour visual traits that are derived from high-level image object 
descriptors according to human understanding. In particular, image features that were 
designed to represent a range of image objects may not be ideal to describe tumour 
phenotypes. The challenge of image-genomics hence lies in the extraction of imaging 
representations to quantify tumour phenotypic characteristics. A secondary challenge 
lies within the image feature extraction technique, as it requires a large amount of 
disease-specific medical image datasets; such datasets are difficult to acquire, in 
addition to the need for precise annotations. 
In this thesis we propose a deep domain adaptation learning framework for 
associating image features to tumour genetic information. Our approach exploits the 
potential of domain adaptation technique for image-genomics to quantify image 
features based on similar knowledge domains. This is accomplished by facilitating the 
learning of tumour image representations with larger datasets from similar domains to 
reduce the reliance on large volumes of disease-specific datasets for image-genomics 
research.  
In addition, our proposed framework enables the extraction of additional 
tumour visual descriptors to provide abstract image representations for associating 
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with gene expressions. It leverages the current state-of-the-art in image object 
recognition to provide image features which encode subtle variations of tumour 
phenotypic characteristics. The quantification of such features is facilitated by the 
employment of domain adaptation techniques. 
We evaluated our proposed deep domain adaptation learning framework by 
comparing with current state-of-the-art in: (i) tumour histopathology image 
classification and; (ii) the degree of image-genomics associations, compare with 
human-crafted tumour image descriptors. 
Our results demonstrated that the proposed deep domain adaptation learning 
framework facilitates the learning of image descriptors and improves the accuracy of 
tumour classification. Our framework has also shown to provide additional image 
features that encode abstract representations of tumour phenotypic characteristics 
which exhibit stronger associations to patient-specific genetic information, compared 
to current state-of-the-art image-genomics analysis. This thesis advances the state-of-
the-art in image-genomics by proposing a novel deep domain adaptation learning 
framework to offer additional image features for image-genomics analysis. The work 
in this thesis indicates the potential of image-genomics research to reveal additional 
imaging surrogates to genetic biomarker, which can be used to facilitate cancer 
diagnosis.   
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Chapter 1 
Introduction 
The current practices for the treatment of human cancers rely upon the establishment 
of accurate diagnosis, which may involve a series of complex medical procedures 
comprising of patient screening for symptom evaluation, non-invasive imaging for 
disease localisation and histopathology analysis of tissue specimens. In recent years, 
genetic sequencing is becoming an increasingly important addition to the existing 
diagnostic pipeline. Cancer diagnosis may be the result of analysis of data generated 
through each medical examinations; the integration of such data contributes towards 
the understanding of the disease and hence exhibit potentials to offer optimal cancer 
therapy at individual patient level [1]. 
Although medical imaging and general pathology are becoming more routine 
in current cancer diagnosis, genetic sequencing is not always practical. This is due to 
human cancers exhibits strong phenotypic and genetic heterogeneity, where disease 
develops at multiple sites with genetic differences [2]. It is not practical or feasible to 
obtain tissue samples from all sites of disease as invasive biopsies have the potential 
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to induce tumour haemorrhage/proliferation. Further, the cost of genetic examination 
is high in addition to its limited accessibility.  
As an alternative, medical images provide non-invasive assessments of 
phenotypic diversities in a number of cancer types and contribute to clinical decision-
making, e.g., tumour detection, subtype characterisation and treatment responses [3, 
4]. Advances in computerised medical image analysis allow the extraction of tumour’s 
visual representations (features) to facilitate the characterisation of tumour phenotypic 
differences, which offers insights into the patterns of disease spread and prognosis. 
The association between tumour imaging features and genetic foreknowledge allows 
the derivation of imaging surrogates to genetic biomarkers, and ultimately lead to the 
emerging field of image-genomics [5]. 
Image-genomics aims to associate the tumour imaging trait and clinical data 
(e.g., the underlying tumour gene expression) to provide an alternative approach that 
contributes to a non-invasive and accurate cancer diagnosis [6]. As such, the discovery 
and extraction of optimised tumour imaging descriptors represent a major challenge in 
the current image-genomics research. 
This thesis address this challenge in the domain of medical image analysis, 
where our approach offers additional image features with domain adaptation technique 
to encode extra tumour phenotype representation. This thesis describes research to 
address the two key hypotheses: can domain adaptation facilitate medical image 
analysis and processing applications? If so, is domain adaptation capable of deriving 
tumour visual descriptors that produce stronger associations with genetic 
information? 
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1.1 Motivation 
Precision medicine refers to the approach of disease prevention, treatment and care 
that takes into account individual variability in genes, environment, and lifestyle [1]. 
Precision medicine allows the classification of individuals into cohorts who are 
susceptible to particular diseases and forecasts response to a specific treatment, 
thereby improving disease prognosis [7]. The combined knowledge of patient’s 
genetics, bioinformatics, imaging and proteomics ultimately contribute towards the 
optimisation of therapeutic strategies [8]. One of the near-term focus of precision 
medicine is with cancer, a disease that is among the leading causes of death incidence 
worldwide. Traditional cancer therapeutics involve the utilisation of existing 
knowledge of the clinical outcomes from previous patient populations to draft 
treatment plans for future patients. Precision medicine has the potential to improve 
clinical oncology practices by utilising the molecular profile of cancer genetic 
behaviour, together with patient’s biological information, to optimise treatment plans 
at individual patient level [9].  
However, pathways to cancer diagnosis are complicated and rarely 
straightforward. Cancer diagnosis may be the result of analysis of data generated by a 
series of medical procedures including non-invasive medical imaging, invasive tumour 
biopsies, genetic sequencing or from other evaluation of symptoms [10, 11]. Such 
procedures are prone to diagnostic errors, time-consuming and expensive in labour. In 
particular, obtaining tissue samples are not always feasible or practical as human 
cancers display phenotypic and genetic heterogeneity with multiple sites and genetic 
differences of the disease. 
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Medical imaging is a fundamental aspect of modern healthcare and plays an 
important role in cancer diagnosis and post-treatment monitoring. Medical images 
encode visual features which represent cancer phenotypic characteristics such as 
cancer location, size, texture and shape, which are useful for disease diagnosis and 
oncologic research [12]. Furthermore, the growing quantity and quality of medical 
images allow the creation of big data-driven approaches to computer-aided diagnosis 
(CAD, where clinicians routinely utilise CAD tools such as segmentation and 
registration to aid in their interpretation and decision making, as well as automated 
detection and classification of diseases as the second opinion to improve diagnostic 
accuracy [13, 14]. 
Although medical imaging is now a routine for cancer diagnosis, patient-
specific genetic information can be valuable for its ability to reveal the underlying 
tumour biology and mutation types [15, 16]. Unfortunately, most human cancers 
exhibit strong genotypic heterogeneity, implying that tumours may have different gene 
expression at various sites and thus limits the usage of surgical operations such as 
tumour biopsies. In addition, tumour heterogeneity exhibits the potential requirement 
for multiple tumour biopsies during the diagnosis, the process of which further escalate 
the expenses along with patients discomfort, and risks the occurrence of undesired side 
effects such as tumour haemorrhage [17-19].  
Imaging surrogates that reflect tumour genetic information have been explored 
as an alternative approach to invasive biopsies for genetic sequencing. This is achieved 
by associating tumour imaging descriptor with the tumours’ underlying genetic 
information which exhibits strong potential to the discovery of tumour biomarkers, 
and has been a key factor for the emergence of “image-genomics” domain [20, 21]. 
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Image-genomics aims to convert tumour imaging data into high-dimensional image 
features to derive associations with tumour genetic information through the use of 
quantitative feature extraction techniques [20].   
In the medical domain, image-genomics has potential applications in medical 
image analysis and biomedical research. Recent studies have demonstrated the 
capability of associating tumour image features with genetic information [22]; and the 
feasibility for potential non-invasive imaging surrogates to specific tumour prognosis 
biomarkers through the use of image-genomics [23]. Image-genomics approaches 
have also been shown to associate image features to a number of biological molecules 
and processes such as the transcriptome [24]. Furthermore, studies suggested that 
image-genomics associations are capable of predicting clinical outcomes in 
hepatocellular carcinoma [25, 26]. 
Despite the advances in image-genomics for identifying imaging surrogate to 
genetic biomarkers, there is an inherent reliance on tumour imaging representations 
for use in the association. The current state-of-the-art image-genomics approach 
employs image features that are defined based upon the human understanding of a 
range of objects (we denote this as human-crafted image features). The direct 
employment of such image object descriptors (by extracting human-crafted image 
features from medical images) is restricted by its capacity to fully quantify tumour 
imaging descriptors and therefore unable to reflect specific cancer types, nor variants 
among the patient cohorts. An alternative approach is to extract additional image 
representations that describe the subtle variations in tumour images, which are 
potentially important to specific tumour types [27]. The quantification of such abstract 
image features offer complementary information to existing image-genomics approach 
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and have the opportunities to: (i) derive stronger associations to gene expressions and; 
(ii) explore and discover additional surrogate non-invasive imaging biomarkers. 
 Another challenge that exists in the field of image-genomics is the lack of 
annotated medical images for rare diseases or different image modalities, where large 
volumes of annotated datasets are required for the learning of image representations 
of particular diseases [22, 28]. The demand for such datasets limits the image-genomic 
applications to specific disease types or image modalities. This restricts the ability to 
derive associations between image features with tumour underlying gene expressions.  
 
1.2 Aims and Objectives 
In this thesis, we address the identified challenges through: (i) the extraction of 
additional image representation to specific cancer types and; (ii) overcome the reliance 
of large volumes of annotated datasets with a novel image-genomics framework. Our 
framework leverages deep learning image analysis and domain adaptation techniques 
to extract disease-specific abstract image representations for associating tumour gene 
expressions.  
 Our framework expands upon traditional approaches in medical image feature 
extraction by adapting the state-of-the-art deep learning techniques for image object 
recognition, and hence offering additional tumour image descriptors for genetic 
associations. The thesis address the following two aims: 
1. The development of a medical image analysis scheme with domain adaptation 
approach. The proposed scheme emphasis on the learning of tumour image 
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representations which leads to the enhanced performance of medical image 
analysis applications, e.g., tumour image classification. 
2. The derivation of an image feature extraction scheme based on deep learning 
techniques to quantify additional image representation from tumour image 
through the employment of domain adaptation technique to associate with 
tumour genetic information. 
 
1.3 Contributions of this thesis 
Our contributions can be summarised in the following two major areas: 
Image Classification and Domain Adaptation  
Chapter 4 presents our contribution towards the domain adaptation facilitated 
medical image analysis scheme with limited volumes of datasets. In our thesis, the 
tumour classification system employs the domain adaptation technique from 
different clinical histopathology images to facilitate the prediction of the presence 
of abnormalities. Our system overcomes the reliance of large volumes of annotated 
datasets and offers improved tumour classification accuracy through the utilisation 
of domain adaptation technique compared to the traditional approach.  
Image-Genomics Framework 
Detailed in Chapter 5, we present a new image-genomics framework to associate 
tumour imaging representations to the underlying tumour gene expressions. Our 
framework utilises the current state-of-the-art in image object recognition to learn 
the abstract image representations that describe the subtle variations in tumour 
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images through a domain adaptation facilitated data-driven approach. Our 
framework utilises different mathematical and genetic analysis tools to associate 
extracted image features to cellular pathways as well as cancer prognostic 
biomarkers. 
 
1.4 Thesis Structure 
The remainder of this thesis is structured as follows: 
 Chapter 2 and 3 orients the readers by providing theoretical background 
knowledge of the thesis. Chapter 2 provides an overview of medical imaging and the 
image processing techniques within this domain. Chapter 3 presents the overview of 
the state-of-the-art in the image-genomics analysis. In particular, it provides a 
summary of gaps from recent image-genomics research.  
 Chapter 4 and 5 provide the detailed contribution of this thesis. We describe 
the domain adaptation facilitated medical image analysis system in chapter 4. In 
chapter 5 we highlight the deep domain adaptation learning framework for associating 
image features to tumour genetic information.  
 Chapter 6 summarises the contribution of this thesis and indicates directions 
for future research in the domain of image-genomics analysis. 
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Chapter 2 
Background and Related Concepts 
2.1 Medical Imaging and Image Processing 
Medical imaging is a fundamental component of the modern healthcare system and is 
essential for the accurate diagnosis and staging of cancers. Medical images provide a 
fast and non-invasive assessment of phenotypic diversity in many cancers [12] through 
a variety of different imaging modalities (or techniques). Medical image processing, 
in turn, allows the extraction of meaningful information which offers insights of 
different aspects of patients’ conditions. In this chapter, we provide an overview of 
medical imaging and the theoretical background in image processing techniques that 
are crucial for cancer diagnosis.  
 
2.1.1 Definitions 
Digital images consist of a collection of numerical picture elements, called pixels. The 
term pixel resolution refers to the number of pixels in an image, which can be 
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represented as a single number or by the number of pixels in each dimension. For 
example, an image that contains 8,294,400 pixels can also be referred to as having a 
resolution of 8.3 megapixels or 3840 ×2160 (width × height) pixels. 
 Many medical imaging techniques consist of sampling 2D images along a third 
spatial axis to form 3D images, known as volumetric images or image volumes. These 
3D volumetric images encode the spatial relationships between 3D pixels, called 
voxels, which both 2D and 3D images allow the extraction and interpretation of the 
encoded information through the use of image processing techniques. Both pixels and 
voxels exhibit spatial resolutions, which describe the size of the details captured by 
individual pixels or voxels. For instance, a spatial resolution of 10.00mm × 10.00mm 
× 5.00mm means that a voxel depicts a region with a volume of 500.00mm3. 
Contrast resolution refers to the range of distinct intensity or a set of intensities 
for red, green and blue (RGB) channels that can be distinguished in greyscale and 
coloured images respectively. A relatively low contrast resolution can be interpreted 
as pixel/voxel intensities that are similar in an image and are difficult to distinguish. 
Figure 2.1: Pixels, voxels and spatial resolutions of medical images: (a) illustrate a 2D 
image with pixel resolution of 8 × 8 and a spatial resolution of 1mm × 1mm. (b) 
illustrate a 3D image volume with voxel resolution of 5 × 5 × 3 where its spatial 
resolution is 1mm × 1mm × 1mm. 
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Figure 2.1 illustrates an example of a 2D image and a 3D volumetric image. Pixels and 
voxels are visualised in forms of 2D and 3D arrays of grids respectively. 
 In medical image processing, a region of interest (ROI) consists collections of 
pixels in 2D images that represent an area which encodes important information for 
particular domain or application in cancer diagnosis. The corresponding term volume 
of interest (VOI) refers to the emphasised anatomical structures that encode important 
knowledge for clinical uses. 
 
2.1.2 Medical Imaging Modalities 
Modern healthcare utilises different medical imaging modalities to capture different 
aspects of the human body for cancer diagnostic and treatment [29, 30]. Medical image 
modalities can be categorised into two classes based on their technique and process in 
visualising different aspects of the disease [31]: (i) Anatomical and (ii) Physiological 
(functional) imaging. Anatomical medical images capture and visualise the anatomical 
structures of the ROI in the form of 2D or 3D images. Anatomical medical images 
allow physicians to interpret and evaluate the disease conditions for diagnosis 
purposes, and can also be used for the monitoring of treatment responses [4]. 
Functional imaging, on the other hand, captures the metabolic status of the ROI, which 
allows physicians to assess the physiological status of patients, and to identify 
structures with abnormalities, such as tumours [32]. 
Common anatomical medical image modalities include X-ray, computed 
tomography (CT), magnetic resonance imaging (MRI). Common functional imaging 
includes single-photon emission computed tomography (SPECT) and positron 
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emission tomography (PET). Such image techniques produce a single type of image 
or image volumes that are referred as single-modality medical imaging. 
Beyond the use of single-modality medical images for cancer diagnosis, the 
employment of multi-modality imaging types such as PET/CT and SPECT/CT has 
become one of the fundamental diagnosis protocol in clinical practices and basic 
medical research [33]. Despite multi-modality medical imaging exhibits strong 
potential to offer both tumour anatomical and functional properties, the evaluation of 
our proposed image-genomic framework did not directly involve datasets with 
multiple modalities. In this subsection, we emphasise on several single modality 
imaging techniques that are most relevant to our contribution. 
2.1.2.1 Computed Tomography (CT) 
Computed tomography is one of the most utilised imaging modalities in cancer 
detection, diagnosis and prognosis in modern clinical practices [34, 35]. CT scan 
makes use of the combination of multiple X-ray measurements to produce 
tomographic images. Figure 2.2 illustrates an example of CT image of the lung field 
from a Non-small Cell Lung Cancer Patient (NSCLC). In the coming chapters, we will 
explore the use of CT image volume with medical image analysis techniques, 
Figure 2.2: The CT image of the lung field from a 
NSCLC patient (data description detailed in Chapter 5). 
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including image feature extraction and its association to tumour phenotypic 
characteristics, which is the most relevant to our thesis contribution. 
2.1.2.2 Digital Histopathology Images 
Tumour histopathology is considered as the golden standard for cancer diagnosis. It is 
produced as the result of tumour tissue biopsies, where specimens of tumour tissue are 
stained and mounted onto glass slides for visual inspection [36]. Tumour 
histopathology offers the visualisation of cellular structures of tumour-containing 
ROIs, providing diagnostic information on mutated cell types, and hence offer 
therapeutic insights about the disease [36, 37]. 
The digitisation of histopathology was introduced through high-resolution 
whole-slide-imaging (WSI), which have enabled the quantitative analysis of tumour 
histomorphometry as well as its association with clinical practices for cancer diagnosis 
(a) Overview of WSI (b) A zoomed-in view of a WSI region 
Figure 2.3: The overview and zoom-in view of WSI of sentinel lymph node with 
presence of breast cancer metastases. (a) The highest-level view of the entire WSI. 
(b) The zoom-in view of a region from the same WSI image (data description 
detailed in Chapter 4) 
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[21, 38]. Similar to CT images, digital WSI enables medical image analysis techniques 
to be applied to extract image features of abnormal cells. Image traits can then be 
exploited to correlate to genetic profiles of the tumour. Figure 2.3 illustrates an 
example of sentinel lymph node WSI with the presence of breast cancer metastases. 
 
2.1.3  Medical Image Segmentation 
This subsection describes several approaches for medical image segmentation that are 
most relevant to our contribution. We describe the current automated image 
segmentation approaches and compare with manual image segmentation by 
experienced physicians to reflect their distinct advantages. 
Medical image segmentation refers to the process of image partitioning where 
each image partition contains a collection of pixels that together represent an ROI [39]. 
Medical image segmentation is commonly used to identify and emphasise ROIs, as it 
(a) The region of interest (lung cancer) 
in a CT image 
(b) The region of interest (Breast 
cancer metastases) in a 
histopathology image 
Figure 2.4: The segmented region of interests in different medical 
image modalities. (a) The dineated presence of lung cancer in an CT 
image. (b) The segmented regions in a WSI that shows the presence of 
breast cancer metastases in sentinel lymph node. 
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removes unrelated image regions to reduce the complexity of medical image analysis 
[40]. 
 Medical image segmentation with manual delineation from experienced 
physicians is considered as the golden standard in most clinical applications. However, 
the current procedure of medical image segmentation for cancer patients relies upon 
the visual inspection of imaging data and the manual delineation of tumour ROI. 
Figure 2.4 provides examples of ROIs in different medical image modalities that were 
delineated by experienced physicians. The production of delineated tumour imaging 
data is time-consuming and prone to diagnostic errors, based on the expertise of the 
physician [41]. These challenges are exacerbated by the requirement of identifying 
quantitative morphological parameters of tumours such as shape and size [42].  
 To address this issue, computerised automated algorithms have been designed 
to facilitate medical image segmentation tasks. Commonly used medical image 
segmentation algorithm involves: pixel thresholding [43], region growing [44], edge 
detection [45] and fuzz clustering [46]. In the recent years, deep learning has also been 
utilised to perform classification and image segmentation tasks and achieved improved 
performance [47, 48]. Despite the performance improvement by deep learning-based 
approaches, few studies have shown superior accuracy to human perception in cancer 
diagnosis [49, 50]. The contribution of this thesis relies on accurate tumour 
delineations for domain adaptation purpose; we hence obtained tumour segmentation 
from experienced physicians as the foundation of our work. We will discuss the 
principle and applications of deep learning in later sections of this chapter. 
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2.2 Gene Expression Profiling 
While the visual inspection of tumour histopathology is considered to provide a 
definitive diagnosis, it is prone to diagnostic errors in diseases where tumour 
classification is challenging due to visually indistinguishable morphological properties 
(e.g. diffuse large B-cell lymphoma and breast cancer) [51, 52]. Gene expression 
profiling refers to the technique of quantitative measurement of genetic activities that 
facilitate tumour classification and is also capable of predicting the clinical outcome 
for cancer patients [53]. In this subsection, we will describe the core concept of genes, 
gene expressions and its application in clinical applications that are relevant to our 
contribution. 
A gene refers to a specific region of the deoxyribonucleic acid (DNA) strands, 
which exhibits genetic codes that produce ribonucleic acid (RNA) through 
transcription. RNAs are capable of synthesising proteins that encode biological 
functions through translation. However, human genetic codes are prone to mutation, 
permanent alteration of genetic elements that can be caused by many different factors 
such as DNA damage from environmental factors. Mutations can result in various 
types of changes in human DNA and may result in changes in behaviour as well as 
functions of genes. Clinical studies have shown evidence of genetic mutations in the 
prognosis of multiple human cancers [54-57].  Gene expression profiling identifies 
genes with abnormal expressions in tumour samples, thus offering insights into 
therapeutic options [16]. Gene expression profiling also provides patient-specific 
genetic information with normal expressions which encodes the genetic variables at 
the individual level that can ultimately contribute to the application of precision 
medicine [58]. 
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 Despite the significance of gene expression profiling in the diagnosis and 
prognosis of cancer patients, gene expression profiling is limited due to its reliance on 
invasive surgical procedures. Unfortunately, human cancers exhibit strong phenotypic 
and genetic heterogeneity within an individual with tumour manifestation at multiple 
sites [59]. Additionally, the differences in gene expressions across multiple sites may 
result in different responses to treatments [60]. The sampling and tissue acquisition of 
tumours from all disease sites is restricted due to patient discomfort and risk of 
undesired side-effects such as operation induced tumour proliferation. This thesis 
addresses this issue through the development of a novel image-genomic framework, 
discussed in detail in the following Chapter 4 and 5 of this thesis. 
2.3 Machine Learning, Deep Learning and 
Convolutional Neural Networks 
Machine learning techniques for medical image processing are a well-established field. 
The ability of machine learning to quantify the representation features of the input 
medical image empowers numerous automated medical image processing algorithms 
for different clinical applications. However, machine learning systems were limited 
due to its requirement of domain expertise with careful engineering to be able to learn 
and transform the input data [61]. Deep learning is a class of machine learning 
technique which allows learning of data representations with multiple layers of 
abstraction. Convolutional neural networks (CNNs) are a deep learning technique that 
extracts image features from imaging data to learn the sophisticated underlying 
representations with deep networks [62]. In this chapter, we emphasise on the principle 
of deep learning and CNNs as they represent the current state-of-the-art in image 
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object recognition. We will present the background and CNN architectures that are 
relevant to our study in the following sections. 
2.3.1  Machine Learning 
Machine learning is a major field of computer science that has been utilised to serve 
many aspects of modern healthcare systems. With carefully engineered mathematical 
models, machine-learning systems have been applied in pattern recognition [63], 
image classification [64], medical image retrieval [65] and tumour image 
segmentation[66]. Compare to the rule-based systems, the core of machine learning 
techniques are based on the development of models from statistical and artificial 
intelligence approaches. It is essential for the machine learning model to “learn” to 
recognise the distinguishing characteristics of the patterns within the data to produce 
meaningful outputs [67]. Generally, the learning approaches for machine learning 
models are divided into the following: supervised learning, unsupervised learning and 
reinforcement learning.  
Although unsupervised and reinforcement learning exhibit strong potentials in 
multiple disciplines, our contribution rely on labelled medical imaging data to explore 
the region-specific genetic association. As the contributions of this thesis involve 
mainly supervised approaches, we will only cover those approaches here. Supervised 
training approaches require several different types of database, defined as follows:  
 Training data: refers to a collection of data that are used to train the machine 
learning model. The machine learning model learns the representation of the 
training data and its predictive relationship to the output labels. 
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 Validation data: refers to a separate collection of data that are used in addition 
to the training data to adjust or guide the training process. This process involves 
the comparison between the predicted output with the training data labels. This 
provides an indication of the performance of the model on unseen data during 
the training process, and allows tuning of model parameters. 
 Test data: refers to a collection of withheld data which is used to evaluate the 
performance of the model at the after the completion of the training process. 
Test data indicates the performance of the trained model with new examples. 
Test data are not involved in the training process. 
2.3.1.1 Supervised Learning: 
Supervised learning is one of the most common approaches for medical image 
processing and analysis. It refers to the approach where the model is trained with 
labelled data sets so that the model learns the internal representation of the input data 
to make predictions on the labels [68]. The resulting model from supervised learning 
is typically used to assign class labels with known predictive features for future data 
sets. Supervised learning is capable of performing classification or regression with 
training data set with discrete or continuous properties, respectively [69]. 
 
2.3.2 Artificial Neural Network 
Artificial Neural Networks (ANNs) are a machine learning approach that was inspired 
by the biological neural networks that constitute human brains [70]. An ANN consists 
a collection of connected nodes or “artificial neurons” in a directed graph in the form 
of networks. ANNs are commonly used in machine learning to learn the complex non-
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linear relationships from the dataset. This is achieved through the ANN’s mechanisms 
where each neuron receives, processes and transmits a signal from one to another in a 
similar way to the biological synapse. To achieve the optimised learning outcome, 
ANN requires the design of an appropriate network structure and learning approach to 
tune the weights and biases of the network. 
Neurons are the fundamental building blocks of many ANNs. Figure 2.5 
illustrates the structure of a single neuron where multiple inputs values are processed 
in the neuron to produce a single output value, where X is a vector of inputs with n 
elements, W is the vector of the weights with a corresponding number of elements, 
which can be summarised in equation 2.3.1: 
L(𝑊, 𝑋) = ∑ 𝑓(𝑥𝑖 , 𝑤𝑖) + bias
𝑛
𝑋=0
   (2.3.1) 
where 𝑓(𝑥𝑖, 𝑤𝑖) is the ANN function that generates the output value. 
 
Figure 2.5: Representation of a single model neuron 
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The training of an ANN can be explained by illustrated single neuron model. 
For each element in the training dataset, its features are extracted and transmitted into 
the neuron in the form of a feature vector. Assuming that the classification task 
involves only two classes, the neuron processes the input feature vector by multiplying 
with its internal weights. A class prediction is based on whether the value of the 
product is above a threshold. If the predicted class does not match the corresponding 
label, each weight within the neuron is adjusted individually to refine the prediction 
process. Additionally, the training dataset is typically divided into collections of 
batches which allows the weight adjustment after training of each batch. An epoch 
refers to the full pass of the entire training dataset; robust weights for classification 
tasks are the outcome of hundreds of training epochs. 
2.3.3 Deep Learning 
Deep learning can be categorised as a class of techniques of machine learning [61], 
which allows the computation models with multiple processing layers to learn the 
internal representation of the input data with multiple levels of abstraction [71]. Deep 
learning was proposed to address the limited performance of traditional machine 
learning approaches to process natural data in their raw form. Deep learning resolves 
this issue by utilising the multiple processing layers to learn and interpret the low level, 
abstract representations from the high-level understandings of the input dataset [61]. 
This is achieved by feeding the raw data through the successive multilayer architecture 
in a sequential manner, where deeper layers learn the abstract representation from the 
representation in the previous layers [67]. 
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Deep learning technique employs backward propagation of error or 
“backpropagation” to train the multilayer model for supervised learning [61]. 
Backpropagation calculates the gradient of the error function of the ANN with respect 
to its weights and passes the gradient backwards through the neural network. 
Compared to the traditional approach where the gradient of the error function is 
calculated for each layer separately, the backflow of error gradient allows more 
efficient computation of gradience for ANNs [72].  
The implementation of deep learning technique utilises specialised GPUs to 
improve the performance of training process by 10 to 20 times compared to the 
traditional training approach on standard CPUs [67]. Recent advances in deep learning 
have lead to the improved state-of-the-art in various domains such as visual object 
recognition [67], speech recognition [73] and also in medical image analysis [42]. 
2.3.4 Convolutional Neural Networks  
Convolutional Neural Networks (CNNs) is a particular type of ANN and designed to 
process input data that is in the form of multidimensional arrays, e.g., coloured 2D 
images which consist of 2D arrays for each RGB (colour) channel. Compared with 
traditional ANNs with fully connected adjacent layers, CNNs are much easier to train 
and are more generalised [67]. CNNs are structured in a series of stages where each 
stage consists of specialised layers with unique functions. The building blocks of a 
CNN consists three types of specialised layers: convolutional, pooling and activation 
layers, e.g., rectified linear unit (ReLU) layers [61]. 
Convolutional layers consist of organised units in the form of feature maps, 
where each unit is connected to local patches from the previous layer through a set of 
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weights which is referred as filter banks as shown in Figure 2.6. The resultant sum of 
the local filter bank is typically transmitted through a non-linear activation layer such 
as ReLU layer, e.g.  𝑓(𝑥) =  𝑚𝑎𝑥(0, 𝑥). Only units within the same feature map share 
the same filter bank. This design allows the convolutional layers to detect local 
conjunctions of features from the previous layer, as local values are often highly 
correlated and are invariant to the location in an image input. 
Pooling layers are designed to merge features in spatial proximity which share 
semantic similarities into one. The principle behind pooling layers is to detect the 
position of motifs that are typically formed by highly correlated features through a 
coarse-grained approach. An example pooling layer calculates the maximum of a local 
patch in one or more feature maps. Pooling layers act to reduce the dimensions of the 
representations and to create an invariance to small distortions and shifts. 
 
 A standard CNN typically involves stacked layers in order of convolution, 
ReLU and pooling layers, and followed by fully connected layers as shown in Figure 
2.7. CNNs also utilise backpropagation to train its filter banks in a similar way 
compare to regular ANNs. 
Figure 2.6: An example 2D convolution of a 3 × 3 input using a 2 × 2 filter with the 
2 × 2 output feature map. 
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 CNNs are inspired by the biological signal transmission through cells with 
different complexity and functions in visual neuroscience [74]. CNNs exploit the 
compositional hierarchies in natural signal processing where high-level features are 
the result of the composition of low-level features, to apply onto images where objects 
are the results of the composition of edges, motifs and parts.  
 CNNs have demonstrated large improvement to the state-of-the-art in multiple 
disciplines. CNNs have been adopted in medical image analysis to perform a range of 
tasks including medical image segmentation [75], classification [76] and disease 
detection [50]. 
 In the following subsections, we will explore the two CNN architectures that 
have shown outstanding performance in image object recognition and that are most 
relevant to our contributions. 
 
Figure 2.7: An example CNN with many convolution layers. Filters are applied to 
each input image and the output of each convolutional layer is used as the input to the 
next layer. 
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2.3.4.1 GoogLeNet (Inception) 
GoogLetNet [77], introduced in 2014 as a submission to the ImageNet Large-Scale 
Visual Recognition Challenge 2014 (ILSVRC14) is a deep CNN architecture consists 
of 22 layers [78]. GoogLetNet was designed to act as a classifier for natural images 
with the underlying concept to increase the width and depth of CNN while keeping the 
computation cost constant. GoogLetNet demonstrated significant improvement to the 
state-of-the-art at the time by achieving a top-5 error of 6.67% for the classification 
challenge. A standard GoogLetNet architecture is shown in Figure 2.8. 
GoogLetNet employs the “inception modules” concept to exploit the 
approximation and coverage of optimal local sparse structure by dense data structures. 
Within each inception model, the input is fed into separated convolution layers with 
dimensions of 1 × 1, 3 × 3, 5 × 5 and a 3 × 3 max pooling layer. Results from each 
layer are concatenated into a single output vector to serve as the input for the next 
stage. 
Also, GoogLetNet exploits the “network-in-network” approach [79] by adding 
a 1 × 1 convolution layer followed by the standard stacked convolutional layers 
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structure for dimension reduction which removes the computation bottleneck and 
hence increases the representational power of the neural network.    
 
2.3.4.2 Deep Residual Networks (ResNet) 
Several studies, including GoogLeNet, have demonstrated that the depth of CNNs is 
one of the crucial factors to improve the learning outcome for image object 
classification tasks with ImageNet dataset [80-82]. However, rapid degradation of 
learning accuracy was observed in CNN architectures that stack many layers together 
Figure 2.8: The GoogLeNet architecture. Layers labeled with “reduce” represents the 
additional 1 × 1 reduction layers before each of the 3 × 3 and 5 × 5 convolutions. 
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in a traditional way. The rationale behind the training degradation was not due to 
overfitting, but an optimisation problem of the mapping of identities for the additional 
layers.  
 ResNet [83] was proposed to address the challenge of training accuracy 
degradation in deep CNN architectures through the use of residual mapping to fit the 
successive stacked layers. ResNet employed the concept of residual representations 
[84, 85] and created a shortcut connection [86] with closed gating functions [87, 88] 
for identity mapping. The residual function and identify mapping by shortcuts are 
according to: 
𝑓(𝑥) = ℋ(𝑥) –  𝑥    (2.3.2) 
where 𝑓(𝑥) denotes the residual function, which is the result of removing the input 𝑥 
of the first layer of the stacked layers from the underlying mapping ℋ(𝑥). Residual 
learning drives the weights of the multiple non-linear layers towards zero to approach 
identity mapping, which is defined as: 
𝑦 = 𝑓(𝑥, 𝑊𝑖) +  𝑥    (2.3.3) 
where 𝑦 and 𝑥 denote the output and the input of the stacked layers respectively and 
𝑓(𝑥, 𝑊𝑖) is the function that represents the residual mapping that needs to be learned. 
The shortcut connections in ResNet does not increase the number of parameters of the 
network nor the computational complexity. A ResNet building block with residual 
learning and shortcut connection is illustrated in Figure 2.9. 
 ResNet further improved the state-of-the-art in image object recognition at a 
top-5 error of 4.49% with a 152-layer ResNet architecture, compared with 6.67% from 
GoogLeNet. ResNet also demonstrates a good generalisation performance for different 
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recognition tasks [83] and hence has been widely adopted in medical image analysis 
[89, 90]. 
2.4 Domain Adaptation for Transfer Learning 
Common applications of machine learning-based techniques involve the training of 
the statistical model to quantify the internal representations of data from the target 
domain. Such an approach relies on the assumption that the training and real-world 
(used in a future application) datasets share the same feature space with a similar 
distribution [91]. The changes of the distribution of feature spaces in the datasets 
typically require that the trained statistical model is rebuilt to fit the newly collected 
data. However, the assumption does not always hold, as most machine learning 
methods require large annotated training datasets that are specific to the target domain. 
Machine learning applications are thus greatly limited in domains such as medical 
image analysis where the acquisition of labelled training data is expensive.  
Transfer learning is the alternative approach to train the statistical model 
without the need for the large quantity of domain-specific datasets. Transfer learning 
refers to the process where the knowledge acquired from one large database is 
Figure 2.9: The building block of ResNet 
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transferred to facilitate learning applications on a related but smaller dataset. For 
neural network applications, transfer learning can be described as an approach to speed 
up the learning of a specific domain by using and transferring the weights obtained 
from a network that was trained for a related source task [92]. An illustration of the 
transfer learning approach is shown in Figure 2.10. 
 Transfer learning technique allows CNNs to be trained and applied to datasets 
from different but related domains. The differences between domains can be 
categorised into two groups: (i) domains with different feature spaces, or (ii) domains 
with the same feature space but different marginal probability distributions [91]. To 
evaluate the representation and the similarity between two domains, techniques such 
as A-distance, have been adopted for transfer learning applications [93, 94].  
There are two major approaches to employ domain adapted transfer learning 
consists for CNNs applications in medical image analysis: (i) using “off-the-shelf 
CNN” features; and (ii) using domain adaptation with fine-tuning techniques [95]. The 
Figure 2.10: Traditional and transfer learning-based approaches for CNN models. a) 
Traditional machine learning. b) Transfer learning-based approach for CNN model. 
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term “off-the-shelf CNN” refers to the procedure of utilising a CNN model which was 
trained on a larger dataset from scratch as a feature extractor directly on a new dataset 
with a smaller volume size. Parameters in the convolutional and fully connected layers 
are not changed. For classification purposes, the extracted features from the “off-the-
shelf-CNN” can be used to train a separate classifier, such as support vector machines, 
random forest classifier or to train only the classification layer of the model to fit the 
number of classes of the new dataset [95-98].  
 
Fine-tuning refers to the process of updating the weights of a pre-trained CNN 
model new datasets from the desired domain through the use of backpropagation. 
Common approaches for fine-tuning involves the training of only the last few 
convolutional layers, referred as “shallow tuning” or the tuning of all convolutional 
layers of the network, called “deep tuning” [99]. Deep tuning is typically employed if 
Figure 2.11: Overview of shallow tuning-based transfer 
learning approach. 
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the distance between domains is significant. The tuning of early layers of CNNs 
involves the learning of low-level image features that are similar to Gabor filters and 
colour blobs, which are applicable to most vision tasks and hence are not applied to 
shallow tuning approach [100]. Studies have shown that fine-tuning is as effective as 
a CNN that is trained from scratch and is more robust to the size of training dataset 
[99].  Fine-tuning has been applied to a variety of medical image analysis tasks such 
as ultrasound anatomy identification and medical image modality classification [89, 
101]. An illustration of “shallow tuning” is shown in Figure 2.11. 
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Chapter 3 
Image-Genomics 
This chapter presents the overview of image-genomics research in various clinical 
contexts. We provide a survey of the current state-of-the-art of image-genomics with 
a focus on the extraction of genetic-related image features, their application to medical 
images with different modalities, and identifying the gaps in the existing approaches. 
 
3.1 Overview of Image-Genomics 
Cancer treatment relies upon accurate diagnosis, which can benefit from accounting 
for individual variabilities in genetics, environment and lifestyle [1], but requires a 
complex combination of information gathered from clinical, histopathology, imaging, 
and genetic data. Medical imaging is one of the fundamental protocols in modern 
healthcare for the examination of human cancers [12]. It offers a fast and non-invasive 
assessment of tumour visual characteristics which can be used as oncologic diagnosis 
tool as well as providing treatment guidance. Briefly discussed in previous chapters, 
computerised analysis of medical images has been demonstrated that quantitative 
33 
 
image feature analysis is capable of capturing distinct tumour phenotypic 
characteristics, e.g. in soft tissue sarcomas (STSs) [102], lung adenocarcinoma [22] 
and colorectal cancers [103], thereby indicating the potential for image features 
analysis to discover and identify tumour imaging biomarkers. The patient-specific 
genetic information also offers insights into therapeutic options and hence can be used 
to optimise patients management and treatment plans, for example, the use of immune-
modulating therapies in melanoma and lung cancer [104]. Also, patient-specific 
genetic data have been used in medical research to analyse high-dimensional mineable 
characteristics, which consists detailed characterisation of biological information such 
as DNA (genomics), RNA (transcriptomics), proteins (proteomics) and metabolites 
(metabolomics) [105].  
Nevertheless, the clinical implementations are restricted by the challenges in 
acquiring tumour genetic profiles. As previously described in Chapter 1 and 2, human 
cancers exhibit strong phenotypic and genetic heterogeneity, where different gene 
behaviours are expressed in various tumour regions. Thus the potential need for 
multiple biopsies may introduce further risk of patient discomfort and the occurrence 
of undesired side effects such as tumour haemorrhage. As such, the consequence is 
that multiple biopsies are rarely performed [17-19]. 
 The emerging field of image-genomics involves the integration of patient-
specific clinical information from both imaging and genetics [106]. Image-genomics 
can be thought of as the identification of surrogate tumour biomarkers through 
correlating image features with gene expression and has been suggested as a non-
invasive alternative to biopsies [5, 107]. It aims to covert clinical images into high 
dimensional mineable image features using quantitative, high-throughput feature 
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extraction algorithms for correlation to genetic information [12, 108]. Studies have 
shown promising result in identifying prognostic image-genomics biomarkers for 
several cancers including lung cancer [109], breast cancer [110], and high-grade 
primary brain tumours [111].  
 As such, current image-genomics research requires large volumes of annotated 
multi-dimensional data. The following clinical data are essential for image-genomics 
studies: 
 Segmented medical images with precise annotations 
 Annotated clinical metadata which provides patient-specific clinical 
parameters 
 Labelled patient-specific gene profile or raw expression array data 
At the current stage, most of the image-genomics research is limited to the 
publically available datasets that are published in The Cancer Imaging Archive (TCIA) 
[112] and The Cancer Genome Atlas [113], or data that is privately collected. The 
limited amount and quality of the dataset make image-genomic research more 
challenging, for example, the confined feature selection process due to the inadequate 
amount of clinical metadata and annotations.  
 In the following subsections, we will explore the use of image features and the 
techniques for image feature extraction in various contexts. Figure 3.1outlines the 
crucial procedures of an image-genomic framework. We will focus on the extraction 
of image features from two of the widely adopted imaging modalities: CT and 
histopathology and their corresponding application in the field of image-genomics.  
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3.2 Image Feature Extraction 
The famous quotation from Bartlett,“A picture is worth ten thousand words”1, 
illustrates the amount of information encoded within a single image. Similar to the 
human behaviour, computerised image analysis techniques extract and select 
information from images to solve problems in various contexts. This is facilitated 
through the employment of models that were trained on specific domains [114]. 
Briefly mentioned in Chapter 2, image feature extraction is a process which 
finds and transforms image encoded information into suitable image representations 
to be used for various applications [115-117]. In the field of image analysis, extracted 
image features can be categorised into global, which are calculated from the entire 
image, or local features, which are extracted from specific ROIs. Image features that 
are applicable to many vision tasks consist colour, texture, shape and the structural 
representation of an image. 
Texture-based features are one of the most important characteristics to 
identify objects and ROIs in an image. Texture is an innate property of surfaces in an 
image regardless of its modality [118] and contains crucial information about the 
structural arrangements of surfaces as well as its relationships to the surrounding 
environment of the ROIs. Texture-based features offer a precise description of the 
homogeneity of the local spatial variation of pixel intensity [119] and texture analysis 
serves computerised applications in image segmentation [120], classification [121] 
and pattern recognition [122].  Commonly adopted texture-based features include the 
use of Haralick and wavelet features [123, 124]. Haralick features are extracted from 
                                                 
1 Original Chinese proverb, writing “畫意能達萬言”. 
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the distribution of co-occurring pixel values in the image within a specified spatial 
neighbourhood, hence providing a statistical summary of the relative distribution of 
gray tones in the image [118]. 
The extraction of texture features through the use of wavelets have also 
contributed to tasks such as content-based image retrieval [125], segmentation [126] 
and classification [127]. Wavelet features are extracted by decomposing the signal of 
images at various resolutions based on wavelet orthonormal [128]. The orthogonal 
multi-resolution representation provides a hierarchical framework to offer image 
characteristics in a coarse-to-fine strategy that extracts contextual and low-level image 
features [127, 128]. 
Colour-based features are one of the most adopted representations of images 
due to its robustness to background complications, as well as its independence to the 
size and orientation fo the image [129]. Colour features also offer both global and local 
image representations with various applications. Colour representations such as colour 
indexing, colour descriptors and compact colour moments have been adopted in 
applications such as image retrieval [130-132] and scene recognition [133]. Colour 
histograms provide insights on global colour distribution and ranges, and have been 
used in applications such as face detection [134] and bleeding detection in medical 
domain [135]. Additionally, the application of colour-based image representations to 
the three-channel domain offers complementary characteristics of the image compared 
to single-channel grayscale images [136]. 
Shape-based features offer descriptions to quantify the shape of ROIs in ways 
that agree with human perception for specific tasks [137]. Shape representations 
capture the geometric details within the ROIs of an image, and are invariant to 
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translation, rotation, scaling and resistant to noise [129]. Shape-based features have 
been extracted and applied through multiple approaches. For 2D images, shape-based 
features have been represented as point sets [138], outline curves [139] and shock 
graphs [140]. Such features have been adopted for image object classifications [141], 
recognition [142] and content-based image retrieval in various domains [143]. 
In 3D volumetric images, commonly adopted shape features use spherical 
harmonics that decompose the 3D object into orientation invariant and descriptive 
information [144]. Additional approaches for 3D shape-based features extraction 
involve the analysis of object surface curvature and the correlograms of the objects 
from various view points [145]. Such 3D shape-based features have been widely used 
in 3D model search engines [144], classification tasks [146] and content-based 
retrieval [147].  
 In addition to the image features that quantify the statistical information of 
pixels (hereafter referred to as “agnostic features”), yet another set of features have 
been commonly utilised to represent high-level tumour characteristics based upon 
human understanding (hereafter referred to as “semantic features”), e.g. tumour 
shape, size and necrosis [105]. Different from agnostic features, semantic features are 
commonly used by radiologists to describe tumours, with the foreknowledge of their 
prognostic value in cancer treatment [148]. The employment of semantic features in 
image-genomics studies has demonstrated their capability to identify prognostic 
imaging biomarkers [23] and to predict gene expression patterns in hepatocellular 
carcinoma [149]. As a collection, agnostic and semantic features quantify the image 
representation of tumour phenotypic traits that are based on established human 
knowledge in cancer physiology. To differentiate such a collection of image features 
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from artificial intelligence produced image descriptors, agnostic and semantic features 
are hereafter referred to as “human-crafted” features.  
Human-crafted image features have been an integral component of image-
based CAD systems [150] in many clinical applications such as disease detection and 
classification [151, 152], improving diagnostic performance [153] and ROI 
segmentations [154]. 
3.3 Summary of Gaps 
A number of image-genomics approaches have been proposed and validated for 
different image modalities and clinical applications across various cancer types. The 
multiplicity of image-genomics research has encouraged studies to employ images 
with multiple modalities and to seek correlations with different genetic information. 
 Recent image-genomics research stimulated the extraction and quantification 
of image features that can be significantly correlated to genetic information. Other 
recent image-genomics studies attempted to derive image features from multi-
modality images, e.g., PET/CT, to provide quantification of tumour phenotype as well 
as its underlying metabolic status to identify imaging surrogate of prognostic 
biomarkers [23].  
 Despite the progress and advances in image-genomics, a number of gaps 
remain unaddressed in the current state-of-the-art. In the following subsections, we 
provide a detailed explanation of aspects that should be pursued and improved to better 
seek image-genomics associations.  
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3.3.1    Medical Image Feature Extraction 
Although current image-genomics approach has been validated in a number of clinical 
research, there is a gap in the quantification and selection of medical image features. 
Neither agnostic features nor semantic features were designed based on particular 
cancer or tissue type, thus may not be optimised to capture the subtle, low-level 
descriptions of specific disease or patients cohort [27]. As a result, human-crafted 
image features lack the ability to fully capture tumour phenotypic characteristics, 
where crucial biomarker may be encoded. Thus, the use of complementary image 
features that are optimised to represent specific disease and patient cohorts would be 
advantageous for future image-genomics studies. 
 Additionally, the curse of dimensionality is an issue to be addressed in current 
state-of-the-art. The process of feature extraction and selection should take into 
consideration of the available genetic biomarkers. Parameters from the clinical 
metadata have been adopted in studies to perform image feature stability test, hence 
offering features that are most stable in the patient cohort [22, 23]. 
 The adoption of new imaging techniques in clinical practices also offer 
opportunities to derive image features with unique advantages. The investigation and 
extraction of new and more genetic related image features will also bring advantages 
for future image-genomic research. 
3.3.2    Domain Adaptation 
Discussed in the previous subsections, current image-genomics studies rely heavily on 
large volumes of multi-dimensional data. However, such datasets are difficult to 
acquire in addition to the need for precise annotations. As such, we suggest that the 
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employment of domain adaptation from our proposed framework exploits the data 
availability and hence reduce the reliance on large datasets for image-genomics 
research. 
 Domain adaptation has been widely adopted in image processing and analysis 
field and is a well-established tool to address the challenge of an insufficient amount 
of annotated medical image datasets. We have briefly discussed the fundamental 
concepts behind domain adaptation in Section 2.3.4. However, the current state-of-
the-art in image-genomics relies solely on datasets that are either exclusively to the 
authors or publically available data. Hence studies that utilised small datasets may not 
be able to extract optimised tumour image representations for associating gene 
expressions. 
Although the utilisation of domain adaptation technique offers opportunities to 
extract tumour descriptors from similar knowledge domains, its potential in image-
genomics applications should be thoroughly examined. Such adaptations will benefit 
future image-genomic explorations where data for particular diseases or patient 
cohorts may be limited. Domain adaptation also has the potential to develop different 
approaches or techniques for image-genomics that are more efficient, practical and 
applicable. 
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Chapter 4 
Domain Adaptation Facilitated 
Medical Image Analysis 
 
This chapter describes our proposed domain adaptation facilitated medical image 
analysis system. The domain adaptation scheme aims to overcome the reliance on large 
volumes of annotated datasets for learning tumour image representations and to 
enhance medical image analysis with regards to tumour image classification. We 
evaluate our method by comparing to the traditional scratch-trained CNNs for tumour 
classification task. Our results indicate that domain adaptation facilitates the training 
process of CNNs and show improved prediction accuracies for the tumour image 
classification tasks where training datasets are limited. 
4.1 Overview 
Tumour histopathology analysis is an important procedure which provides definitive 
cancer diagnosis [36]. However, the current practice to detect the presence of tumour 
43 
 
abnormalities relies upon visual inspection on histopathology slides, which is time-
consuming and prone to diagnostic errors, based upon the expertise of the pathologist. 
These challenges are exacerbated when quantitative histomorphological parameters 
such as mitotic counts and surface areas are required to be identified and extracted. 
The introduction of high-resolution whole-slide imaging (WSI) [155] has 
enabled the digitisation of tumour pathology slides. WSI has given rise to automated 
pathology image processing techniques that have demonstrated improvements in the 
efficiency and accuracy of pathology slide interpretations [156]. 
In this section of the thesis, we propose a domain adaptation facilitated medical 
image analysis system that aims to enhance tumour classification task in WSIs, 
especially in circumstances where labelled training data are limited. The technical 
contribution of this study addresses and overcomes a number of gaps in the medical 
image analysis research: (i) The learning of disease-specific image representations that 
encode tumour phenotypic characteristics and; (ii) to overcome the reliance of large 
volumes of annotated datasets for learning disease-specific image representations.  
Detailed in Chapter 3, deep learning-based approaches have been widely 
adopted in medical image analysis, including applications in histopathology images. 
Recent deep learning methods for image classification and detection using CNNs have 
demonstrated marked improvements in the performance of a range of medical imaging 
analysis tasks, e.g., nuclei segmentation [76] and tissue classification [157]. However, 
most well-established deep learning methods require large annotated training datasets 
that are specific to the particular problem domain [61]; such datasets are difficult to 
acquire for histopathology data where visual characteristics differ between different 
tissue types, in addition to the need for precise annotations.  
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 Our proposed system employs domain adaptation and deep learning-based 
techniques to learn the image representations of tumour phenotypic characteristics 
from WSIs with similar knowledge domain. Such image representations were 
employed to facilitate the tumour classification task with limited volumes of annotated 
medical image datasets. 
4.1.1 Framework Overview 
Figure 4.1 outlines the main procedures of the proposed domain adaptation facilitated 
tumour classification framework. The proposed framework initiates with an image pre-
processing step where WSIs were processed to extract tumour-bearing and non-tumour 
patches for both datasets (please see section 4.2 for details of the datasets). Shown in 
Figure 4.1, a standard CNN model was trained from an annotated breast cancer dataset 
to learn abstract image representations of WSIs as part of the pre-training phase. In the 
fine-tuning phase, we optimise the initial weights from the pre-trained CNN to be more 
representative of the subtle variations in visual characteristics from a relatively smaller 
dataset that contains prostate cancer WSIs. Result evaluation calculates the 1) 
prediction accuracy with a subset of prostate cancer dataset; 2)  The sensitivity and 
specificity of the classifier to plot an operational receiver characteristic graph. Section 
4.5 and 4.6 provide detailed evaluation strategy and result interpretation, respectively. 
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4.2 Datasets 
We used high-resolution WSIs from two cancer types: 
 Lymph node metastases dataset: We used 110 WSIs of metastases-containing 
sentinel lymph nodes digitised at a maximum of 40× magnification from the 
Camelyon-16 challenge dataset [22]. The ground truth data were provided in 
the form of WSI binary masks to indicate the regions of metastatic breast 
cancer. We randomly selected 100 WSIs for training and 10 WSIs for 
validation. This dataset was used as the larger set for CNN pre-training. 
 Prostate cancer dataset: We used the publically available prostate fused-MRI-
pathology dataset from the Cancer Imaging Archive (TCIA) [23, 24], 
comprising of 16 biopsies confirmed subjects of radical prostatectomy 
specimens. Each prostate specimen was digitised at 20× magnification and 
digitally stitched together from 4 separate slides to form a larger pseudo-
mounted histopathology image. Ground truth annotations of cancer presence 
were made by an expert pathologist. We removed one subject from the study 
due to missing annotations. We randomly assigned the pseudo-mounted 
histopathology slides if the remaining subjects into two datasets: twelve were 
used for a training/fine-tuning dataset and three were used for the test dataset. 
 
4.3 Image Pre-processing and Patch Extraction 
The white background space of WSIs contains no meaningful information and hence 
are removed in most classification methods [158]. We removed the background using 
a well-established threshold method based on the optical density of the RGB channels 
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of the WSI [42]. For each colour channel c, we calculated the optical density dc across 
the set of all pixels P, according to: 
dc(P ) = log10
Ic(p)
Imax
     (4.1) 
where Ic(p) is the intensity of pixel p in channel c and Imax is the maximum intensity of 
the channel, which is 255 with 8-bit quantisation. We removed the background by 
thresholding the original image where dc(P) < 0.2. Figure 4.2 illustrates the resulted 
binary masks which containing only the tissue regions of the WSI.  
 
a) 
b) 
Figure 4.2: Histopathology slides with background information 
removed. a) The original tumour containing histopathology slide of 
prostate. b) The binary masks containing only tissue regions of the 
histopathology slide.  
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Due to the size of each WSI image (up to several gigapixels), we randomly 
extracted patches of size 256 × 256 pixels from WSIs with background removed. 
Tumour patches were those where ≥ 50% of the total pixels belonged to the tumour 
regions while non-tumour patches were those where none of the pixels belonged to the 
tumour. To avoid bias in the training dataset, we selected an equal number of tumour 
and non-tumour patches from the entire set; this prevented oversampling predominant 
non-tumour patches. In total, we obtained 272540 patches from the lymph node 
metastases training set and 22086 patches from the validation set. For the prostate 
cancer dataset, we obtained a total of 4196 patches from the training slides and 274 
patches from the test slides. 
4.4 CNN Training and Fine-Tuning 
We chose the GoogLeNet CNN for our method due to its state-of-the-art performance 
in WSI cancer detection in the Camelyon 16 challenge [159]. We modified the input 
layer to fit the size of the extracted image patches. Our pre-training on the lymph node 
patch dataset (denoted LN) involved finding the set of CNN layer weights WLN that 
minimised the CNN’s empirical loss: 
L(WLN, XLN) = 
1
n
∑ l(GOOG(xi,WLN),C)
n
i=1    (4.2) 
where xi is an image from the set of n images in XLN, GOOG() is a function that 
represents the GoogLeNet architecture to predict the class of xi, given the set of 
weights WLN. C is the ground truth annotation for xi, and l() is a penalty function for 
the class prediction, set to the logistic loss in our research. We determined the weights 
iteratively using mini-batch stochastic gradient descent for 172 epochs (the point at 
which the model converged) so that WLN = W172 given: 
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Wt+1=Wt + η [αΔWt—
δL(Wt,X)
δWt
 −  𝜆Wt]   (4.3) 
where ΔWt −  Wt-1 denotes the weight update from the previous iteration. The batch 
X (a subset of XLN) contained 64 samples, coefficient η = 1 × 10−4 was the learning 
rate that controlled the size of the weight updates, and α = 0.9 was the momentum that 
diminished irregular fluctuations in weight changes across consecutive iterations. In 
our formulation, 𝑾0 was randomly initialized from a uniform distribution with ΔW0 =
0.  
Our fine-tuning stage followed a similar process, substituting the prostate patch 
dataset (denoted PR) instead of the lymph node patch dataset, replacing WLN with WPR 
and XLN with XPR in Equation 4.2. Fine-tuning was iterated for 200 epochs (which is 
when the model converged) so that WPR = W200 given initial weights from the pre-
trained model (W0 = WLN and ΔW0= 0). 
4.5 Evaluation Strategy 
We compared the effectiveness of our system with CNNs which was trained from 
scratch using the prostate dataset. We trained the baseline CNN and our domain-
adapted CNN with different numbers of prostate patches: 0, 1000, 2500 and 4196 
patches. 
The evaluation scheme comprises: 
 Measure the performance of our system in predicting image patches (274 
patches from prostate tumour WSIs) to contain tumour cells, compared with 
scratch-trained CNNs. This scheme reflects the ability of our system to extract 
image features that can differentiate tumour and non-tumour tissues in WSIs. 
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 Compute the area under receiver operating characteristics (AUC) [160] to 
compare the quality of the proposed system with traditional scratch-trained 
CNNs, which reflects the sensitivity (true-positive rate) and specificity (true-
negative rate). 
4.6 Results 
Figure 4.3 illustrates the classification accuracy as it relates to the underlying size of 
the training/fine-tuning dataset; numerical results are provided in Table 4.1. Our 
domain adaptation facilitated system (highlighted in orange colour) achieved higher 
classification accuracy when compared with the traditional scratch-trained GoogLeNet 
architecture. As expected, better classification accuracies were obtained from our 
proposed domain adaptation facilitated training strategy compared to the traditional 
scratched-trained framework. 
 
Figure 4.3: Accuracy of CNNs with various prostate cancer training size from fine-
tuned and scratch-trained strategies. 
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Table 4.2 compares the AUC of the CNNs with different prostate cancer 
training dataset sizes. Our results show that our method has higher AUC values than 
the scratch-trained CNN. This demonstrates that our method enables GoogLerNet to 
perform cancer classification on WSIs with lower true/false positive rates across all 
three prostate cancer training sizes. It also suggests that the representation of WSIs 
derived from the fine-tuned CNN leverages the information from different tissue types 
to improve the specificity and sensitivity of cancer classification tasks. 
Table 4.1: Test accuracy of CNNs from both training approaches for cancer 
classification task with different training size. 
Table 4.2: Area under receiver operation characteristics (AUC) results of CNNs from 
both training approaches to perform cancer classification tasks with different training 
size. 
Prostate cancer 
training size 
GoogLeNet:  
Scratch-trained 
(benchmark) 
GoogLeNet: 
Fine-tuned (Proposed 
method) 
0 66.9% 27.3% 
1000 79.9% 90.0% 
2500 84.5% 91.9% 
4196 86.7% 91.8% 
Prostate cancer 
training size 
GoogLeNet:  
Scratch-trained 
(benchmark) 
GoogLeNet: 
Fine-tuned (Proposed 
method) 
0 50% 33.2% 
1000 74.5% 82.5% 
2500 75.9% 83.9% 
4196 78.8% 84.3% 
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4.7 Discussions and Summary 
Our findings indicate that the proposed domain adaptation facilitated medical image 
analysis system improves the performance of CNNs for cancer classification tasks 
where training datasets are limited. At a dataset of 0 prostate images, the fine-tuned 
model (effectively trained only on lymph node metastases cancer) has an accuracy of 
33.2%. This suggests that the lymph node feature space encodes some but not all of 
the information for classifying prostate images. In addition, the scratch-trained model 
at 0 prostate images (effectively untrained) appears to achieve an accuracy of 50%; 
this is equivalent to random guessing on a two-class dataset. 
 Our results also demonstrate that as the training dataset increases in size, the 
AUC and accuracy of the fine-tuned and scratch trained models to begin to converge; 
this is expected behavior from the employed CNNs, as given sufficiently larger 
training/fine-tuning datasets, each CNN would be able to learn image descriptors that 
are better representative of the specific data domain. As such, our findings suggest that 
our fine-tuning approach enables the classifier to reach its peak performance with 
considerably smaller training volume. This is attributed to its ability to learn subtle 
low-level differences between various tissue types [161], enhancing the ability to 
characterise and differentiate histopathology imaging data for different cancer types.  
Our framework is not specific to particular CNN architecture or a particular 
cancer types. Hence we suggest that our approach has the potential to be extended with 
greater diversity in our training data and the adoption of various CNN models to 
support and improve the classification accuracy for multiple disease types.  
 The results indicate that our proposed domain adaptation facilitated medical 
image analysis system is capable of learning disease-specific image representations 
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that encode tumour phenotypic characteristics for tumour classification task; and 
overcame the reliance of large volumes of annotated datasets for the training process 
of CNN architectures. Our proposed framework allows automated image analysis to 
be applied to more disease types where large volumes of annotated medical image 
datasets are limited, and potentially contributes towards the advances in medical image 
analysis research. 
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Chapter 5 
Deep Image-Genomics 
 
This Chapter details our proposed deep domain adaptation learning framework for 
image-genomics analysis. Our work addresses the current gap in image-genomics 
research to extract additional, complementary image features that encode sophisticated 
abstract representations of tumour phenotypic characteristics for image-genomics 
association. We evaluate our proposed image-genomics framework with the current 
state-of-the-art in image-genomics analysis to compare the degrees of associations 
between image features and the tumour genetic information. Our results suggest that 
the proposed framework provides stable image features to encode tumour phenotypic 
characteristics. Results further indicate that the extracted image features offers 
stronger associations to tumour underlying genetic information and have the potential 
to identify imaging surrogates for tumour prognostic biomarkers. 
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5.1 Overview 
Medical image feature extraction plays a crucial role in image-genomic research. 
Detailed in Chapter 3, one of the gaps in the current state-of-the-art in image-genomics 
research is the inherent reliance on traditional human-crafted features (agnostic and 
semantic) for associating to tumour genetic information.  
 In this thesis, we address this challenge by proposing a deep domain adaptation 
learning framework for associating image features to tumour genetic information. Our 
approach exploits the potential of domain adaptation and deep learning-based 
techniques to quantify additional image representations of tumour phenotypic 
characteristics from medical images with similar knowledge domain. Our framework 
also makes a number of modifications to the current state-of-the-art image-genomics 
approach to enable the extraction of abstract image representations, which encodes the 
subtle variations in tumour images.   
5.2 Framework 
Figure 5.1 outlines the crucial procedures of our proposed image-genomics 
framework, elements that are highlighted in the figure reflects our core contributions. 
The acquired medical image datasets and genetic information were processed with 
tumour sub-region delineations and gene expression normalisation [162] respectively. 
Our framework involves a widely adopted and computational efficient 2.5D 
representation of the tumours’ physical centroids as the input for deep learning-based 
feature extraction [95]. Deep features were extracted through the employment of a pre-
trained CNNs with domain adaptation techniques. Image-genomics associations were 
derived by calculating the Spearman’s rank correlation between extracted image 
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features and the pre-defined gene sets, which are based on medical foreknowledge and 
are available from the Molecular Signatures Database C5 collection [163]. Image-
genomics signatures were also visualised in the form of heat maps to reveal association 
patterns. 
5.2.1 Dataset 
We used the publicly available dataset from the Cancer Imaging Archive (TCIA) 
[112]. The dataset contains 89 histologically confirmed non-small cell lung cancer 
(NSCLC) patients: 29 women, 60 men, stages IA – IV with an age range 37- 85 years. 
All patients underwent a CT scan of the thorax/upper abdomen and a whole body 18F-
FDG-PET-CT. The CT scans excluded tumour annotations. The CT scan slice 
thickness was between 1.5mm and 5mm. Genome-scale gene expression profiles were 
also acquired.  
The three-dimensional tumour sub-regions of 69 patients (23 women, 46 men), 
were manually segmented by an experienced physician. The more detailed patient 
description can be found in Appendix Table A1. The remaining 20 patients from the 
dataset were excluded due to inconsistency of tumour locations that were specified 
between the specialist and the clinical metadata. The exclusion and segmentation were 
performed by a senior experienced medical imaging specialist who has read in excess 
of 80,000 PET-CT scans. The segmentation was done on transverse sections slice-by-
slice, using lung windows, with an open source software tool (Medical Imaging 
Interaction Toolkit (MITK); version 2016.11) [164]. The segmented tumour sub-
regions were used for feature extraction purposes. Gene expression was accessed via 
the Gene Expression Omnibus (GEO) [165]. 
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5.2.2 Tumour Image Feature Extraction 
In this study, we proposed a deep learning-based medical image feature extraction 
scheme to quantify tumour phenotypic descriptors that are complementary to human-
crafted image features. Facilitated by the domain adaptation technique and the 
employment of CNNs, our framework extracted additional abstract image 
representations that were learned from images with similar domains. We also extracted 
human-crafted image features for the purpose of experimental comparisons. The 
following subsections describe the approaches and methods for the quantification of 
deep image features. 
Deep Features: Deep features were extracted from a pre-trained CNN through 
the utilisation of domain adaptation techniques. We employed a 101-layer deep 
residual network (ResNet-101) that was trained on ImageNet ILSVRC challenge data. 
The pre-trained ResNet-101 was chosen as the feature extractor because of its 
performance in natural image classification with 3.57% error rate on the ImageNet test 
set [78, 83]. The top-5 classification error(s) on the validation dataset was 7.1%. The 
hyper-parameters of ResNet-101 comprise the following: input size of 224 × 224, 
weight decay of 1 × 10-4, the momentum of 0.9 with the initial learning rate of 0.1. 
During the training phase, the learning rate was decreased by a factor of 10 after the 
error-rate plateaued. Our implementation used the MatConvNet toolkit [166] and the 
pre-trained CNNs models that were provided in its model library. 
We used a 2.5D representation of the CT data by resampling the axial, sagittal 
and coronal views at the physical centroid coordinates of the tumour; this was utilised 
as the input to the pre-trained ResNet-101 model, shown in Figure 4.2. For each of the 
views, the gray values were normalised to [0, 255] using a linear transformation due 
59 
 
to 8-bit quantisation. All three input slices were then reduced to 224 × 224 with 
nearest-neighbour interpolation as well as zeros padding to preserve the aspect ratio of 
the tumour. Deep features were then derived through the forward propagation of the 
network with different input images, with final features extracted from the pooling 
layer named "pool5". We obtained a total of 6144 image features (2048 for each of the 
three planar views) from the CT volumes of each patient. We removed from the deep 
feature vector of all ‘non-meaningful features’, i.e., those with a median absolute 
deviation (MAD) of 0 across all patients (meaning that they did not vary across 
patients). After this removal, 4436 image features remained for each patient. 
Human-defined Features: We extracted 431 human-crafted image features 
from CT volumes across all patients; their descriptions can be found in the Appendix. 
The human-crafted image features consist the following sub-categories, based on their 
properties: (a) first-order statistics that describe the distribution of voxel intensities, 
(b) shape and size descriptors of tumour geometric 3D characteristics such as 
compactness and surface area, (c) textural features which represent the spatial 
distribution of the voxel intensities, and (d) wavelets features, where the wavelet 
decomposition was applied to the raw image to derive first order statistics and textual 
features for all eight filter channels. Textural features were extracted using gray-level 
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co-occurrence matrix (GLCM) and gray-level run length matrix (GLRLM) toolboxes 
in Matlab 2016b. 
5.3.3 Image-genomic Association and Enrichment Analysis 
Our framework employed the following techniques: (i) Spearman’s rank correlation 
and; (ii) Gene Set Enrichment Analysis (GSEA) [167] to associate image features with 
patient-specific genetic information. We employed the pre-defined gene sets from the 
C5 collection of MsigDB that are based on specific gene ontology term (GO term), 
which denotes one of three categories: molecular function, cellular component or 
biological process in the experiment. Spearman’s rank correlation offered a robust 
estimation of the monotonic relationship between variables and was performed on 
image feature vectors and normalised gene expression to produce a pre-ranked gene 
list [168]. Genes from the pre-ranked gene list that had p-values < 0.001 according to 
the Spearman’s rank correlation were used to derive image-genomics associations. We 
then performed a pre-ranked version of GSEA to derive image-genomics signatures 
with gene sets. We followed the standard protocol by utilising gene sets that have 
Figure 5.2: The 2.5D representation of a tumour physical centroid with axial, sagittal 
and coronal slices of the image volume. The orientation of the CT volume are 
illustrated on the figure: anterior (A), superior (S), posterior (P) and inferior (I). 
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between 15 and 500 contributing genes to calculate the normalised enrichment score 
(NES) as follows: 
𝑃ℎ𝑖𝑡(𝑆, 𝑖) = ∑
|𝑟𝑗|
𝑁𝑅
𝑔𝑗∈𝑆
𝐽≤𝑖
  , 𝑤ℎ𝑒𝑟𝑒 𝑁𝑅 =  ∑ |𝑟𝑗|𝑔𝑗𝜖𝑆                (5.1) 
𝑃𝑚𝑖𝑠𝑠(𝑆, 𝑖) = ∑
|𝑟𝑗|
𝑁𝑅
𝑔𝑗∉𝑆
𝐽≤𝑖
    (5.2) 
where the pre-ranked gene list contains genes g1,...gN that were sorted based on the 
Spearman correlation values r, where r(gj) = rj. The foreknowledge defined gene set 
S contains NH genes. The enrichment score (ES) reflects the degree to which a gene set 
S is over-represented at both extremes of the pre-ranked gene list, and is then defined 
as the maximum deviation from zero of Phit- Pmiss. The normalised ES (NES) is 
calculated through the rescaling of ES by dividing by the means of 1000 permutation 
of ES, where the permutated ES > 0. Ultimately, NES is an indicator of the 
effectiveness of image features to represent a collection of genes in the pre-defined C5 
gene sets. 
5.3.4 Evaluation Strategy 
The evaluation scheme for our experiment was designed to provide a direct 
comparison with the current state-of-the-art image-genomics approach. The proposed 
evaluation strategy consists of measuring of the peak and overall degrees of 
enrichment of image-genomics associations for deep features as follows:  
 Quantification of the effectiveness of deep features in capturing tumour 
phenotypic representations. This is achieved by calculating the association 
between deep features and tumour clinical parameters such as primary tumour 
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stage with the χ2 test. We compared our results with image-genomics 
associations that were derived using the 431 traditional human-crafted features. 
 The measurement of the maximum, minimum and range of NES across all gene 
sets to evaluate the peak performance of image-genomics associations from 
both feature extraction approaches. We performed a two-sample t-test between 
deep learned and human-crafted image-genomics associations by comparing 
the absolute NES to evaluate the degree of enrichment across all gene set.  
 The employment of χ2 test to examine the association between deep features 
and the distribution of gene sets which contains key NSCLC prognostic 
biomarkers. The result indicates the strength of association between image-
genomics signatures and the key prognostic biomarkers. 
5.3 Results 
5.3.1 Deep Features as Tumour Phenotype Descriptor 
Our results demonstrate the associations between extracted deep features and tumour 
phenotypic characteristics in the form of heat map, shown in Figure 5.3. We employed 
unsupervised K-means clustering [169] to reveal three main clusters of patients with 
distinct association patterns. The effectiveness and stability of image features in 
capturing tumour phenotypic characteristics were measured by comparing the clusters 
with tumour clinical parameters (Fig. 5.3b), specifically with primary tumour (T-
stage), lymph node (N-stage) and metastasis (M-stage), which are the standard 
indicator for lung cancer classification [170, 171]. Our results suggest a significant 
association to T-stage (p < 6.8 × 10-3, χ2 test) where cluster I depicted greater 
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association with primary tumour stage pT4. However, image features that were 
extracted from our proposed framework did not show significant association with the 
N-stage and M-stage tumour phenotype (p < 0.48 and p < 0.76, respectively, χ2 test). 
We found similar results from the 431 human-crafted image features, where primary 
tumour T-stage is significantly correlated to human-crafted image features (p < 1.5 × 
10-3, χ2 test) but correlates to neither tumour N-stage nor M-stage (p < 0.68 and p < 
0.82 to N-stage and M-stage respectively, χ2 test). Our findings indicate that both 
image feature extraction approaches share similar capabilities in capturing tumour 
phenotypic representations for our experimental dataset.  
5.3.2 Deep Features Derived Image-genomics Signatures 
The range of enrichment scores across image-genomics associations was used to 
investigate the extreme degrees of enrichment of the pair-wise association between 
extracted image features and pre-defined gene sets. Table 5.1 outlines the maximum, 
minimum and maximum range of NES from image-genomics associations that have a 
false discovery rate that is smaller than the standard threshold of 0.2. Image-genomics 
associations that were derived from deep features are shown to be better enriched to 
ontology gene sets compared to human-crafted image features. The range of NES for 
each image feature reflects the generalisability of the image representations to 
associate with different genetic information. Human-crafted and deep learning derived 
image features exhibits a maximum NES range of 8.22 and 8.46 respectively. Of the 
1046 gene sets, 997 gene sets were shown to have a wider range of enrichment degrees 
when associated with deep features. 
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We also compared the overall performance of image-genomics association for 
image features through the employment of two-sample t-test on the absolute NES, as 
shown in Table 5.2. Image-genomics associations that were derived from deep features 
demonstrate improved degrees of enrichment in 518 of the total 1046 gene sets 
compare to the traditional human-crafted image features. 
The association between gene expression and deep features are illustrated in 
Figure 5.4. Unsupervised K-means clustering reveals the three main gene set clusters 
and five image feature clusters with the distinct association to image features. The 
distribution of gene sets which contains key prognostic biomarker genes are shown in 
Figure 5.4b: (i) epidermal growth factor receptor (EGFR) (ii) ERCC1 and (iii) RRM1. 
Image-genomics signatures are shown to be strongly associated with key prognostic 
biomarkers (p < 1.3 × 10-5, χ2 test). Gene set clusters I and III are observed to be more 
associated with ERCC1, while cluster II and III are associated with biomarker RRM1. 
 
Table 5.1: Statistical analysis of radiogenomic signatures from human-crafted and 
deep learning derived image features. 
Statistical analysis 
items 
Human-crafted features Deep features 
Maximum NES 4.36 4.53 
Minimum NES -4.56 -4.78 
Max NES Range 
(Single feature) 
8.22 8.46 
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5.4 Discussions and Summary 
Our results indicate that our proposed deep domain adaptation learning framework 
provides additional image features that capture tumour phenotypic characteristics, and 
is indicated by the significant association between deep features and tumour primary 
stage (p < 6.8 × 10-3, χ2 test). However, deep features did not show a significant 
association to tumour N-stage nor M-stage. We found similar performance from 
human-crafted image features, which also showed significant association with primary 
tumour stage (T-stage) only. Neither of the image features to have a significant 
association with tumour N-stage nor M-stages, which is potentially attributed to the 
size of experiment dataset, where only a small portion of the patient cohort exhibits an 
N-stage or M-stage.  
 
Table 5.2: Right-tailed two-sample t-test result summarisation of deep-learnt and 
human-crafted features 
 
Deep features vs. Human-crafted features Results 
Signatures with p-values < 0.05 518 
Total Valid Gene Set: 1046 
Better Enriched Gene Sets (%) 49.6% 
Two-sample t-test on NES range  
Gene sets with wider range   997 
Gene sets with wider range (%)  95.3% 
66 
 
Our results also suggest that image-genomics associations were better enriched 
with deep features than to human-crafted image feature. Of the 1046 ontology gene 
sets, deep features have shown superior genetic representation across all gene sets 
compare to human-crafted image features. As shown in Table 5.1, the extreme degree 
of enrichment for both positive and negative correlations was improved through the 
utilisation of deep features. This finding suggests that the proposed framework extracts 
image features that are more capable of capturing the subtle visual variations from 
tumour medical images.  
Further, our results also demonstrate that deep features exhibit stronger image-
genomics associations to ontology gene set, as shown in Table 5.2. This was 
investigated by assessing the range and the absolute means of NES across all gene sets. 
Of the 1046 gene sets, more than 95% of the gene sets have a wider NES range when 
associated with deep features, compared to human-crafted features. Our results reflect 
that deep features-derived image-genomics associations are more representative to 
tumour ontology gene sets, compare to human-crafted image features. Our result hence 
suggests that the subtle visual representations that are encoded in deep features have 
the potential to better reflect tumour genetic information with the same experimental 
dataset, compare to the human-crafted image object descriptors. 
The evaluation of the overall performance of image-genomics associations was 
shown in the form of t-test statistics. Our result indicates that 518 of the total 1046 
gene set have improved absolute mean of NES with deep features. This observation 
illustrates that 49% of the gene sets are better associated with deep features compared 
to human-crafted image features. Our result further suggests that the deep features 
67 
 
have the potential to encode additional tumour phenotypic characteristics that exhibit 
strongly associations with tumour ontology gene sets.  
Furthermore, the unsupervised K-means clustering of gene sets reveals distinct 
patterns with deep features in Figure 5.4. The distribution of gene sets that contain key 
prognostic biomarkers is shown to be associated with the clusters: cluster II is highly 
associated to prognostic biomarker EGFR, and cluster II and III contain prognostic 
biomarker gene RRM1 exclusively. This suggests that deep feature derived image-
genomics associations comprise a distinctive association pattern to key prognostic 
biomarkers in the form of gene sets. Unfortunately, such findings require further 
validation from clinical contexts that needs to be explored for future studies. 
Our proposed framework is not bound to specific CNN architecture or genetic 
information analysis protocols, and is sufficiently flexible to cater for other medical 
image modalities. As such, our framework can adapt to newer and improved CNNs 
architectures, thereby allowing for even better quantification of tumour visual 
characteristics from the medical image data. 
Lastly, the deep domain adaptation learning framework for image-genomics 
analysis offers unique image-genomics associations when compared with the 
traditional human-crafted features. Our work showed improved performances in 
deriving image-genomics associations compared with the traditional human-crafted 
features. Our framework also demonstrated the potential for the extraction of imaging 
surrogates to tumour prognostic biomarkers. Our proposed framework allows a more 
comprehensive quantification of tumour phenotypic characteristics from medical 
images which exhibit potentials to be associated with tumour genetic information. Our 
work advances the current state-of-the-art and facilitates future research in identifying 
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image surrogates for tumour biomarkers, which has the potential to contributes 
towards accurate and non-invasive cancer diagnosis and precision medicine for 
patient-specific treatment. 
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Chapter 6 
Conclusion and Future work 
This chapter highlights the capabilities of our proposed deep domain adaptation 
learning framework for image-genomics analysis, based on our experiments, together 
with the challenges that remain to be investigated. Further discussions on the future 
directions and limitations of our studies will also be addressed in the following 
subsections. 
 
6.1    Conclusion 
In this thesis, we presented novel deep domain adaptation learning framework for 
image-genomics analysis to improve image-genomics association. Our proposed 
framework emphasised the employment of domain adaptation of deep learning in 
image-genomics research to offer additional deep image features that encode abstract 
image representations of subtle variation in tumour medical images. Our domain 
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adaptation approach reduces the dependency on large volumes of annotated medical 
image dataset for deep learning models to learn the tumour image representation. 
 Our results demonstrated that domain adaptation technique facilitates the 
learning of image representations of abnormalities in medical images by extending or 
refining existing knowledge from similar domains. The quantification of such image 
features hence improves the accuracy of tumour image classification tasks, compared 
to traditional approaches where deep learning models were trained from scratch on 
limited volumes of domain-specific datasets. Our results also demonstrated that the 
proposed framework offers additional deep image features to encode abstract 
representation of tumour phenotypic characteristics which exhibit stronger 
associations to patient-specific genetic information, compared to human-crafted image 
features. 
Our findings highlight the potential of deep domain adaptation learning 
framework in the field of image-genomics. With advances in imaging techniques and 
computation tools, the future employment of domain adaptation and deep learning-
based approaches would offer more opportunities to reveal stronger image-genomics 
associations and identify imaging surrogates for tumour genetic biomarkers.  
This thesis has potentially contributed toward the research field of image-
genomics by allowing automated image analysis to be applied to more disease types 
where large volumes of annotated medical image datasets are limited. Our proposed 
deep domain adaptation learning framework also has the potential to contribute 
towards accurate and non-invasive cancer diagnosis and hence the clinical application 
of precision medicine for patient-specific treatment in the near future. 
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6.2 Future Research Directions 
A number of new techniques and tools are now emerging to offer more opportunities 
in the field of image-genomics, e.g. advances in imaging agents prostate-specific 
membrane antigen (PSMA) PET/CT scans [172]. Image features that are extracted 
from our proposed domain adaptation scheme have the potential to be further fine-
tuned. As described in Chapter 2 and 4, fine-tuning allows the image representation to 
be more optimised to the dataset, which may further improve image-genomics 
associations with gene expressions.  
In addition, detailed clinical description with more characteristics of patients 
would also help future studies in the training of CNNs model, feature selection and to 
refine radiogenomics signatures to specific clinical parameters. Improved image 
feature selection could avoid over-fitting and hence reduce the number of false-
positive radiogenomic signatures or vice versa. 
 Furthermore, patients can also be highly heterogeneous in many aspects: age, 
gender, hereditary, cell type and cancer stage. Those can be potentially reflected on 
their medical images and hence accounted for the image feature extraction process. 
With more clinical data made public in the future, future image-genomics framework 
has the potential to take account of patients’ variability into the design of CNN 
architecture, image feature selection and to refine image-genomics associations. Such 
techniques allow more applications of image-genomics and open the door to greater 
clinical impact such as clinical trails. 
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Appendix 
 
Table A1. Patients’ characteristics of the NSCLC data set (n = 69). 
Variable Counts (Frequency %) 
Gender  
Male 46 (66.7%) 
Female 23 (33.3%) 
T-stage  
T1 21 (30.4%) 
T2 30 (43.4%) 
T3 15 (21.7%) 
T4 2 (2.9%) 
Tx 1 (1.4%) 
N-stage  
N0 48 (69.6%) 
N1 13 (18.8%) 
N2 5 (7.2%) 
Nx 3 (4.3%) 
M-stage  
M0 64 (92.8%) 
M1 4 (5.8%) 
Mx 1 (1.4%) 
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Human-crafted Image Features 
We have extracted a total number of 431 image features from CT volumes from the 
NSCLC dataset. The extracted image features can be sub-divided into the following 
groups, based on their feature properties (see Chapter 3 and 4 for feature description): 
1. First order statistics 
2. Shape and size based image features 
3. Textural features 
4. Wavelet features 
First order statistics  
Let X denote the three dimensional CT volume with N voxels. The first order 
histogram P with Nl discrete intensity levels. The following fourteen features were 
extracted in our experiment: 
A1. Energy: 
𝑒𝑛𝑒𝑟𝑔𝑦 =  ∑ 𝑋(𝑖)2
𝑁
𝑖
 
A2. Entropy: 
𝑒𝑛𝑡𝑟𝑜𝑝𝑦 =  ∑ 𝑃(𝑖) log2 𝑃(𝑖)
𝑁𝑙
𝑖
 
A3. Kurtosis: 
𝑘𝑢𝑟𝑡𝑜𝑠𝑖𝑠 =  
1
𝑁
∑ (𝑋(𝑖) − ?̅?)4𝑁𝑖=1
(√
1
𝑁
∑ (𝑋(𝑖) − ?̅?)4𝑁𝑖=1 )
2
 
where ?̅? denotes the mean of X. 
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A4. Maximum: 
The maximum voxel intensity value in the CT volume X. 
A5. Mean: 
𝑚𝑒𝑎𝑛 =  
1
𝑁
∑ 𝑋
𝑁
𝑖
(𝑖) 
A6. Mean absolute deviation: 
The mean of the absolute deviation of all voxel intensities around the mean 
intensity in the CT volume X. 
A7. Median: 
The median voxel intensity value in the CT volume X. 
A8. Minimum: 
The minimum voxel intensity value in the CT volume X. 
A9. Range: 
The range of voxel intensity values in the CT volume X. 
A10. Root mean square (RMS): 
𝑅𝑀𝑆 =  √
∑ 𝑋(𝑖)2𝑁𝑖=1
𝑁
 
A11. Skewness: 
𝑠𝑘𝑒𝑤𝑛𝑒𝑠𝑠 =  
1
𝑁
∑ (𝑋(𝑖) − ?̅?)3𝑁𝑖=1
(√
1
𝑁
∑ (𝑋(𝑖) − ?̅?)2𝑁𝑖=1 )
3
 
where ?̅? denotes the mean of X. 
A12. Standard deviation: 
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𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 = (
1
𝑁 − 1
∑(𝑋(𝑖) − ?̅?)2
𝑁
𝑖=1
)
1
2 
where ?̅? denotes the mean of X. 
A13. Uniformity: 
𝑢𝑛𝑖𝑓𝑜𝑟𝑚𝑖𝑡𝑦 =  ∑ 𝑃(𝑖)2
𝑁𝑙
𝑖=1
 
A14. Variance: 
𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒 =  
1
𝑁 − 1
∑(𝑋(𝑖) −  ?̅?)2
𝑁
𝑖=1
 
where ?̅? denotes the mean of X. 
The standard deviation, mean absolute deviation and variance measure the dispersion 
of the intensity histogram of the CT volume X. The skewness measures the degree of 
asymmetry around the mean of the intensity histogram, while kurtosis quantifies the 
sharpness of the intensity histogram. Uniformity and entropy are descriptors for the 
randomness of the intensity histogram.  
Shape and size based features 
The following image features represent the three-dimensional size and shape of the 
tumour VOI. Let V denotes the volume and A the surface area of the volume of the 
VOI: 
A15. Compactness 1: 
𝑐𝑜𝑚𝑝𝑎𝑐𝑡𝑛𝑒𝑠𝑠 1 =  
𝑉
√𝜋𝐴
2
3
 
A16. Compactness 2: 
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𝑐𝑜𝑚𝑝𝑎𝑐𝑡𝑛𝑒𝑠𝑠 2 =  36𝜋
𝑉2
𝐴3
 
 
A17. Maximum 3D diameter: 
The maximum three-dimensional tumour diameter is measured as the largest 
pairwise Euclidean distance between voxels on the surfaces of the tumour VOI. 
A18. Spherical disproportion: 
𝑠𝑝ℎ𝑒𝑟𝑖𝑐𝑖𝑡𝑦 𝑑𝑖𝑠𝑝𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛 =  
𝐴
4𝜋𝑅2
 
A19. Sphericity: 
𝑠𝑝ℎ𝑒𝑟𝑖𝑐𝑖𝑡𝑦 =  
𝜋
1
3(6𝑉)
2
3
𝐴
 
A20. Surface area: 
The surface area is measured as the sum of the number of border voxels that 
are located on each slice of the tumour VOI.  
A21. Surface to volume ratio: 
𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑡𝑜 𝑐𝑜𝑙𝑢𝑚𝑒 𝑟𝑎𝑡𝑖𝑜 =  
𝐴
𝑉
 
 
A22. Volume: 
The volume of the tumour VOI is measured by the total count of voxels in the 
tumour region and multiplying by the voxel size. 
The maximum 3D diameter, surface area and volume feature quantify the size of the 
tumour VOI. Compactness, spherical disproportion, sphericity and the surface to 
volume ratio offer information to describe the shape aspects of the tumour VOI. 
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Textural features 
This group of image features describes the patterns and spatial distribution of voxel 
intensities in the tumour VOI. In this thesis, the extracted gray-level co-occurrence 
(GLCM) and gray-level run-length (GLRLM) texture matrices were employed to 
describe the texture features of the tumour VOIs. 
 
Gray-Level Co-Occurrence Matrix based features 
A GLCM is defined as P(i,j;δ,α), P is a matrix with the size of Ng × Ng , where Ng 
denotes the number of discrete gray-level intensities in the VOI. The element at (i,j) 
denotes the number of co-occurrence of intensity values i and j in two voxels that are 
separated by a distance of δ voxels in the direction α. In our experiment, the distance 
δ was set to 1 with 13 directions in three dimensions for α. In addition, we denote the 
following terms, let: 
μ be the mean of P(i,j), 
 𝑝𝑥(𝑖)  =  ∑ 𝑷(𝑖, 𝑗)
𝑁𝑔
𝑗 = 1  be the marginal row probabilities, 
 𝑝𝑦(𝑖)  =  ∑ 𝑷(𝑖, 𝑗)
𝑁𝑔
𝑖 = 1  be the marginal column probabilities, 
μx be the mean of 𝑝𝑥, 
μy be the mean of 𝑝𝑦, 
σx be the standard deviation of 𝑝𝑥, 
σy be the standard deviation of 𝑝𝑦, 
𝑝𝑥+𝑦(𝑘) =  ∑ ∑ 𝑷(𝑖, 𝑗)
𝑁𝑔
𝑗 = 1
𝑁𝑔
𝑖 = 1 , 𝑤ℎ𝑒𝑟𝑒 𝑘 =  𝑖 + 𝑗, 𝑘 =  2,3, … ,2𝑁𝑔, 
𝑝𝑥−𝑦(𝑘) =  ∑ ∑ 𝑷(𝑖, 𝑗)
𝑁𝑔
𝑗 = 1
𝑁𝑔
𝑖 = 1 , 𝑤ℎ𝑒𝑟𝑒 𝑘 =  |𝑖 − 𝑗|, 𝑘 =  0,1, … , 𝑁𝑔 − 1, 
𝐻𝑋 =  − ∑ 𝑝𝑥(𝑖) log2[𝑝𝑥(𝑖)]
𝑁𝑔
𝑖=1 , be the entropy of 𝑝𝑥, 
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𝐻𝑌 =  − ∑ 𝑝𝑦(𝑖) log2[𝑝𝑦(𝑖)]
𝑁𝑔
𝑖=1 , be the entropy of 𝑝𝑦, 
𝐻 =  − ∑ ∑ 𝑷(𝑖, 𝑗)
𝑁𝑔
𝑗 = 1
𝑁𝑔
𝑖 = 1 log2[𝑷(𝑖, 𝑗)], be the entropy of 𝑷(𝑖, 𝑗), 
𝐻𝑋𝑌1 =  − ∑ ∑ 𝑷(𝑖, 𝑗)
𝑁𝑔
𝑗 = 1
𝑁𝑔
𝑖 = 1 log(𝑝𝑥(𝑖)𝑝𝑦(𝑗)), and 
𝐻𝑋𝑌2 =  − ∑ ∑ 𝑝𝑥(𝑖)𝑝𝑦(𝑗)
𝑁𝑔
𝑗 = 1
𝑁𝑔
𝑖 = 1 log(𝑝𝑥(𝑖)𝑝𝑦(𝑗)). 
A23. Autocorrelation: 
𝑎𝑢𝑡𝑜𝑐𝑜𝑟𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛 =  ∑ ∑ 𝑖𝑗𝑷(𝑖, 𝑗)
𝑁𝑔
𝑗=1
𝑁𝑔
𝑖=1
 
A24. Cluster prominence: 
𝑐𝑙𝑢𝑠𝑡𝑒𝑟 𝑝𝑟𝑜𝑚𝑖𝑛𝑒𝑛𝑐𝑒 =  ∑ ∑[𝑖 + 𝑗 − 𝜇𝑥(𝑖)  −  𝜇𝑦(𝑗)]
4𝑷(𝑖, 𝑗)
𝑁𝑔
𝑗=1
𝑁𝑔
𝑖=1
 
A25. Cluster shade: 
𝑐𝑙𝑢𝑠𝑡𝑒𝑟 𝑠ℎ𝑎𝑑𝑒 =  ∑ ∑[𝑖 + 𝑗 − 𝜇𝑥(𝑖)  −  𝜇𝑦(𝑗)]
3𝑷(𝑖, 𝑗)
𝑁𝑔
𝑗=1
𝑁𝑔
𝑖=1
 
A26. Cluster tendency: 
𝑐𝑙𝑢𝑠𝑡𝑒𝑟 𝑡𝑒𝑛𝑑𝑒𝑛𝑐𝑦 =  ∑ ∑[𝑖 + 𝑗 − 𝜇𝑥(𝑖)  −  𝜇𝑦(𝑗)]
2𝑷(𝑖, 𝑗)
𝑁𝑔
𝑗=1
𝑁𝑔
𝑖=1
 
A27. Contrast: 
𝑐𝑜𝑛𝑡𝑟𝑎𝑠𝑡 =  ∑ ∑ |𝑖 − 𝑗|2𝑷(𝑖, 𝑗)
𝑁𝑔
𝑗=1
𝑁𝑔
𝑖=1
 
A28. Correlation: 
𝑐𝑜𝑟𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛 =  
∑ ∑ 𝑖𝑗𝑷(𝑖, 𝑗) −
𝑁𝑔
𝑗=1
𝑁𝑔
𝑖=1 𝜇𝑥(𝑖)𝜇𝑦(𝑗)
𝜎𝑥(𝑖)𝜎𝑦(𝑗)
 
A29. Difference entropy: 
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𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑒𝑛𝑡𝑟𝑜𝑝𝑦 =  ∑ 𝑷𝑥−𝑦(𝑖) log2[𝑷𝑥−𝑦(𝑖)]
𝑁𝑔−1
𝑖=0
 
A30. Dissimilarity: 
𝑑𝑖𝑠𝑠𝑖𝑚𝑖𝑙𝑎𝑟𝑖𝑡𝑦 =  ∑ ∑ |𝑖 − 𝑗|𝑷(𝑖, 𝑗)
𝑁𝑔
𝑗=1
𝑁𝑔
𝑖=1
 
A31. Energy: 
𝑒𝑛𝑒𝑟𝑔𝑦 =  ∑ ∑[𝑷(𝑖, 𝑗)]2
𝑁𝑔
𝑗=1
𝑁𝑔
𝑖=1
 
A32. Entropy (H): 
𝑒𝑛𝑡𝑟𝑜𝑝𝑦 =  − ∑ ∑ 𝑷(𝑖, 𝑗)
𝑁𝑔
𝑗=1
𝑁𝑔
𝑖=1
log2[𝑷(𝑖, 𝑗)] 
A33. Homogeneity 1: 
ℎ𝑜𝑚𝑜𝑔𝑒𝑛𝑒𝑖𝑡𝑦 1 =  ∑ ∑
𝑷(𝑖, 𝑗)
1 + |𝑖 − 𝑗|
𝑁𝑔
𝑗=1
𝑁𝑔
𝑖=1
 
A34. Homogeneity 2: 
ℎ𝑜𝑚𝑜𝑔𝑒𝑛𝑒𝑖𝑡𝑦 2 =  ∑ ∑
𝑷(𝑖, 𝑗)
1 + |𝑖 − 𝑗|2
𝑁𝑔
𝑗=1
𝑁𝑔
𝑖=1
 
A35. Informational measure of correlation 1 (IMC1): 
𝐼𝑀𝐶1 =  
𝐻𝑋𝑌 − 𝐻𝑋𝑌1
𝑚𝑎𝑥{𝐻𝑋, 𝐻𝑌}
 
A36. Informational measure of correlation 2 (IMC2): 
𝐼𝑀𝐶2 =  √1 −  𝑒−2(𝐻𝑋𝑌2−𝐻𝑋𝑌) 
A37. Inverse Difference Moment Normalised (IDMN): 
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𝐼𝐷𝑀𝑁 =  ∑ ∑
𝑷(𝑖, 𝑗)
1 + (
|𝑖 − 𝑗|2
𝑁2
)
𝑁𝑔
𝑗=1
𝑁𝑔
𝑖=1
 
A38. Inverse Difference Normalised (IDN): 
𝐼𝐷𝑁 =  ∑ ∑
𝑷(𝑖, 𝑗)
1 + (
|𝑖 − 𝑗|
𝑁 )
𝑁𝑔
𝑗=1
𝑁𝑔
𝑖=1
 
A39. Inverse variance: 
𝑖𝑛𝑣𝑒𝑟𝑠𝑒 𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒 =  ∑ ∑
𝑷(𝑖, 𝑗)
|𝑖 − 𝑗|2
𝑁𝑔
𝑗=1
𝑁𝑔
𝑖=1
, 𝑖 ≠ 𝑗 
A40. Maximum probability: 
𝑚𝑎𝑥𝑖𝑚𝑢𝑚 𝑝𝑟𝑜𝑏𝑎𝑏𝑖𝑙𝑖𝑡𝑦 =  𝑚𝑎𝑥{𝑷(𝑖, 𝑗)} 
A41. Sum average: 
𝑠𝑢𝑚 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 =  ∑[𝑖𝑷𝑥+𝑦(𝑖)]
2𝑁𝑔
𝑗=2
 
A42. Sum entropy: 
𝑠𝑢𝑚 𝑒𝑛𝑡𝑟𝑜𝑝𝑦 =  ∑ 𝑷𝑥+𝑦(𝑖) log2[𝑷𝑥+𝑦(𝑖)]
2𝑁𝑔
𝑖=2
 
A43. Sum variance: 
𝑠𝑢𝑚 𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒 =  ∑(𝑖 − 𝑆𝐸)2𝑷𝑥+𝑦(𝑖)
2𝑁𝑔
𝑖=2
 
A44. Variance: 
𝑣𝑎𝑟𝑖𝑎𝑛𝑐𝑒 =  ∑ ∑(𝑖 − 𝜇)2𝑷(𝑖, 𝑗)
𝑁𝑔
𝑗=1
𝑁𝑔
𝑖=1
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Gray-Level Run-Length matrix based features 
The gray-level run-length matrix is employed to quantify the number of consecutive 
pixels that have the same gray level in an image. Given a gray-level run-length matrix 
𝑝(𝑖, 𝑗|𝜃), the element at (𝑖, 𝑗) describes the number of times, denoted as 𝑗, of pixels 
with gray level of 𝑖 appears consecutively in the direction of  𝜃. 𝑁𝑔 denotes the number 
of discrete gray-level intensities. In our research, we computed GLRL matrix with 13 
directions in the three-dimensional CT image volumes. The following GLRL features 
were extracted in the experiment, let: 
𝑝(𝑖, 𝑗|𝜃) be the (𝑖, 𝑗)th entry in the gray-level run-length matrix 𝑝 in direction 
𝜃. 
𝑁𝑟 denotes the number of different run lengths, 
𝑁𝑝 denotes the number of voxels in the image volume. 
 
A45. Short Run Emphasis (SRE): 
𝑆𝑅𝐸 =  
∑ ∑ [
𝑝(𝑖, 𝑗|𝜃)
𝑗2
]𝑁𝑟𝑗=1
𝑁𝑔
𝑖=1
∑ ∑ 𝑝(𝑖, 𝑗|𝜃)𝑁𝑟𝑗=1
𝑁𝑔
𝑖=1
 
A46. Long Run Emphasis (LRE): 
𝐿𝑅𝐸 =  
∑ ∑ 𝑗2𝑝(𝑖, 𝑗|𝜃)𝑁𝑟𝑗=1
𝑁𝑔
𝑖=1
∑ ∑ 𝑝(𝑖, 𝑗|𝜃)𝑁𝑟𝑗=1
𝑁𝑔
𝑖=1
 
A47. Gray Level Non-Uniformity (GLN): 
𝐺𝐿𝑁 =  
∑ [∑ 𝑝(𝑖, 𝑗|𝜃)𝑁𝑟𝑗=1 ]
2𝑁𝑔
𝑖=1
∑ ∑ 𝑝(𝑖, 𝑗|𝜃)𝑁𝑟𝑗=1
𝑁𝑔
𝑖=1
 
A48. Run Length Non-Uniformity (RLN): 
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𝑅𝐿𝑁 =  
∑ [∑ 𝑝(𝑖, 𝑗|𝜃)
𝑁𝑔
𝑖=1 ]
2𝑁𝑟
𝑗=1
∑ ∑ 𝑝(𝑖, 𝑗|𝜃)𝑁𝑟𝑗=1
𝑁𝑔
𝑖=1
 
A49. Run Percentage (RP): 
𝑅𝑃 =  ∑ ∑
𝑝(𝑖, 𝑗|𝜃)
𝑁𝑝
𝑁𝑟
𝑗=1
𝑁𝑔
𝑖=1
 
A50. Low Gray Level Run Emphasis (LGLRE): 
𝐿𝐺𝐿𝑅𝐸 =  
∑ ∑ [
𝑝(𝑖, 𝑗|𝜃)
𝑖2
𝑁𝑟
𝑗=1 ]
𝑁𝑔
𝑖=1
∑ ∑ 𝑝(𝑖, 𝑗|𝜃)𝑁𝑟𝑗=1
𝑁𝑔
𝑖=1
 
A51. High Gray Level Run Emphasis (HGLRE): 
𝐻𝐺𝐿𝑅𝐸 =  
∑ ∑ 𝑖2𝑝(𝑖, 𝑗|𝜃)𝑁𝑟𝑗=1
𝑁𝑔
𝑖=1
∑ ∑ 𝑝(𝑖, 𝑗|𝜃)𝑁𝑟𝑗=1
𝑁𝑔
𝑖=1
 
A52. Short Run Low Gray Level Emphasis (SRLGLE): 
𝑆𝑅𝐿𝐺𝐿𝐸 =  
∑ ∑ [
𝑝(𝑖, 𝑗|𝜃)
𝑖2𝑗2
𝑁𝑟
𝑗=1 ]
𝑁𝑔
𝑖=1
∑ ∑ 𝑝(𝑖, 𝑗|𝜃)𝑁𝑟𝑗=1
𝑁𝑔
𝑖=1
 
A53. Short Run High Gray Level Emphasis (SRHGLE): 
𝑆𝑅𝐻𝐺𝐿𝐸 =  
∑ ∑ [
𝑝(𝑖, 𝑗|𝜃)𝑖2
𝑗2
𝑁𝑟
𝑗=1 ]
𝑁𝑔
𝑖=1
∑ ∑ 𝑝(𝑖, 𝑗|𝜃)𝑁𝑟𝑗=1
𝑁𝑔
𝑖=1
 
A54. Long Run Low Gray Level Emphasis (LRLGLE): 
𝐿𝑅𝐿𝐺𝐿𝐸 =  
∑ ∑ [
𝑝(𝑖, 𝑗|𝜃)𝑗2
𝑖2
𝑁𝑟
𝑗=1 ]
𝑁𝑔
𝑖=1
∑ ∑ 𝑝(𝑖, 𝑗|𝜃)𝑁𝑟𝑗=1
𝑁𝑔
𝑖=1
 
A55. Long Run High Gray Level Emphasis (LRHGLE): 
𝐿𝑅𝐻𝐺𝐿𝐸 =  
∑ ∑ 𝑝(𝑖, 𝑗|𝜃)𝑖2𝑗2𝑁𝑟𝑗=1
𝑁𝑔
𝑖=1
∑ ∑ 𝑝(𝑖, 𝑗|𝜃)𝑁𝑟𝑗=1
𝑁𝑔
𝑖=1
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Wavelet features: wavelet decompositions 
Wavelet transformation allows the decomposition of images in low- and high-
frequencies. Our experiment involves the application of a discrete, one-level and 
undecimated three-dimensional wavelet transformation to each of the CT image 
volumes. The original CT image volume X was decomposed into eight 
decompositions. Let L and H denote the low- and high-pass function respectively. The 
resulted decompositions of X are labelled as XLLL,  XLLH, XLHL, XLHH, XHLL, XHLH, XHHL 
and XHHH. The decomposition of XLHL represents the directional filtering of X with low-
pass filters along the x- and z-directions, and a high-pass filter along the y-direction 
given Equation A66: 
𝑋𝐿𝐻𝐿  =  ∑ ∑ ∑ 𝐿(𝑝)𝐻(𝑞)𝐿(𝑟)𝑋(𝑖 + 𝑝, 𝑗 + 𝑞, 𝑘 + 𝑟)
𝑁𝐿
𝑟=1
𝑁𝐻
𝑞=1
𝑁𝐿
𝑝=1
  
where 𝑁𝐿 denotes the length of filter L while 𝑁𝐻 denotes the length of filter H. In our 
experiment, wavelet “Coiflet 1” was applied to CT image volumes to derive all 8 
decompositions. The first order statistics (group 1) and textural features (group 3) were 
computed for each of the decompositions. 
 
 
 
